Shinhan Financial Group Co., Ltd(NYSE:SHG)

Shinhan Financial Group Co., Ltd. provides financial products and services in South Korea and internationally. It offers various deposits; personal, corporate, and investment finance, as well as business loans; and trust, foreign exchange, fund, bancassurance, and internet banking services. The comp...
Website: http://www.shinhangroup.com
Founded: 2001
Full Time Employees: 167
Sector: Financial Services
Industry: Banks-Regional
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-11-14 | 2025-08-14 | 2025-05-15 | 2025-03-18 | 2025-03-04 | 2024-11-14 | 2024-08-14 | 2024-05-16 | 2024-03-18 | 2024-03-04 | 2023-11-14 | 2023-08-14 | 2023-05-15 | 2023-03-15 | 2022-03-03 | 2021-11-17 | 2021-05-20 | 2021-03-03 | 2020-05-15 | 2019-05-21 | 2019-03-11 | 2017-11-14 | 2015-08-17 | 2015-05-15 | 2015-03-10 | 2011-11-29 | 2010-11-15 | 2010-08-16 | 2010-03-31 | 2010-02-26 | 2009-05-15 | 2009-03-31 | 2009-02-19 | 2008-12-31 | 2008-11-14 | 2008-08-14 | 2007-08-14 | 2007-05-15 | 2007-04-02 | 2006-11-21 | 2005-12-31 | 2005-11-17 | 2004-04-13 | 2003-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance at january 1, 2024 | 2,969,641,000,000 | |||||||||||||||||||||||||||||||||||||||||||
total comprehensive income | ||||||||||||||||||||||||||||||||||||||||||||
profit for the period | 2,499,281,000,000 | -16,896,000,000 | 1,328,049,000,000 | 1,364,977,000,000 | 1,248,976,000,000 | -43,649,000,000 | -43,354,000,000 | 1,018,593,000,000 | ||||||||||||||||||||||||||||||||||||
other comprehensive income, net of income tax: | ||||||||||||||||||||||||||||||||||||||||||||
gain on valuation and disposal of securities at fair value through other comprehensive income | ||||||||||||||||||||||||||||||||||||||||||||
equity in other comprehensive income of associates | 4,297,000,000 | |||||||||||||||||||||||||||||||||||||||||||
foreign currency translation adjustments for foreign operations | ||||||||||||||||||||||||||||||||||||||||||||
net change in unrealized fair value of cash flow hedges | ||||||||||||||||||||||||||||||||||||||||||||
net finance expense on insurance contract assets | ||||||||||||||||||||||||||||||||||||||||||||
net finance expense on reinsurance contract assets | ||||||||||||||||||||||||||||||||||||||||||||
remeasurements of the net defined benefit liabilities | ||||||||||||||||||||||||||||||||||||||||||||
changes in own credit risk on financial liabilities designated at fair value through profit or loss | ||||||||||||||||||||||||||||||||||||||||||||
total other comprehensive income | ||||||||||||||||||||||||||||||||||||||||||||
other changes in equity | ||||||||||||||||||||||||||||||||||||||||||||
annual dividends | ||||||||||||||||||||||||||||||||||||||||||||
quarterly dividends | ||||||||||||||||||||||||||||||||||||||||||||
dividends to hybrid bonds | ||||||||||||||||||||||||||||||||||||||||||||
issuance of hybrid bonds | -797,866,000,000 | |||||||||||||||||||||||||||||||||||||||||||
redemption of hybrid bonds | ||||||||||||||||||||||||||||||||||||||||||||
transfer to retained earnings of redemption loss of hybrid bonds | ||||||||||||||||||||||||||||||||||||||||||||
acquisition of treasury stock | ||||||||||||||||||||||||||||||||||||||||||||
disposal of treasury stock | ||||||||||||||||||||||||||||||||||||||||||||
retirement of treasury stock | ||||||||||||||||||||||||||||||||||||||||||||
change in other capital adjustments | ||||||||||||||||||||||||||||||||||||||||||||
change in other non-controlling interests | ||||||||||||||||||||||||||||||||||||||||||||
reclassification between oci and retained earnings | ||||||||||||||||||||||||||||||||||||||||||||
balance at september 30, 2024 | 2,969,641,000,000 | |||||||||||||||||||||||||||||||||||||||||||
source | 421,849.9 | 403,986.6 | 399,138.7 | 393,366.2 | 388,431.7 | 9,790.8 | 7,216.2 | 4,673.3 | 381,026.9 | |||||||||||||||||||||||||||||||||||
use | 41,399.9 | 38,020.3 | 37,353 | 34,947.1 | 34,849 | 590.8 | 427.2 | 282.3 | 32,964.2 | |||||||||||||||||||||||||||||||||||
interest income | 21,581,000,000 | 20,092 | 20,092 | 20,092 | 6,493 | 1,987,231,000,000 | 25,435,000,000 | 25,566 | 138,472,000,000 | 138,472,000,000 | 39,810,000,000 | 135,503,000,000 | 135,503,000,000 | 35,018,000,000 | 34,507,000,000 | 16,749,000,000 | 61,994,000,000 | 79,151,000,000 | 20,770,000,000 | 17,589,750,000 | 23,975,000,000 | 97,787,000,000 | ||||||||||||||||||||||
interest expense | -83,318,000,000 | 12,952,498,000,000 | 9,496 | -286,642,000,000 | 9,496 | 9,496 | 3,919 | -210,535,000,000 | -52,785,000,000 | -53,280,000,000 | -231,205,000,000 | -54,812,000,000 | -50,188,000,000 | -421,943,000,000 | -45,600,000,000 | -62,576,000,000 | -63,178,000,000 | -4,146,183,000,000 | -93,458,000,000 | 84,831,000,000 | 82,298 | 421,627,000,000 | 116,664,000,000 | 390,602,000,000 | 93,306,000,000 | 90,076,000,000 | 79,891,000,000 | 62,647,000,000 | 129,644,000,000 | 34,737,000,000 | 20,239,750,000 | 28,854,000,000 | 92,616,000,000 | |||||||||||
net interest expense | -61,737,000,000 | -193,138,000,000 | -135,450,000,000 | -33,410,000,000 | -36,311,000,000 | -162,086,000,000 | -41,461,000,000 | -38,226,000,000 | -38,268,000,000 | -48,231,000,000 | -48,382,000,000 | -63,471,000,000 | ||||||||||||||||||||||||||||||||
fees and commission income | 17,759,000,000 | 1,385,507,000,000 | 3,884 | 69,517,000,000 | 3,884 | 3,884 | 951 | 61,050,000,000 | 15,264,000,000 | 15,256,000,000 | 61,923,000,000 | 12,443,000,000 | 12,441,000,000 | 11,679,000,000 | 17,506,000,000 | 17,506,000,000 | 971,484,000,000 | 30,304,000,000 | ||||||||||||||||||||||||||
fees and commission expense | -147,000,000 | 362,535,000,000 | 1,466 | -439,000,000 | 1,466 | 1,466 | 347 | -2,399,000,000 | -251,000,000 | -97,000,000 | -326,000,000 | -93,000,000 | -83,000,000 | -11,000,000 | -28,000,000 | -56,000,000 | -168,541,000,000 | -24,000,000 | ||||||||||||||||||||||||||
net fees and commission income | 17,612,000,000 | 1,022,972,000,000 | 2,414 | 69,078,000,000 | 2,418 | 2,418 | 603 | 58,651,000,000 | 15,013,000,000 | 15,159,000,000 | 61,597,000,000 | 12,350,000,000 | 12,358,000,000 | 11,668,000,000 | 17,478,000,000 | 17,450,000,000 | 802,943,000,000 | 30,280,000,000 | ||||||||||||||||||||||||||
dividend income | 2,560,051,000,000 | 78,727,000,000 | 1,785,967,000,000 | 1,580,222,000,000 | 4,497,000,000 | 1,370,243,000,000 | 1,387,530,000,000 | 1,385,063,000,000 | 1,282,144,000,000 | 1,393,000,000 | 1,063,347,000,000 | 93,478,000,000 | ||||||||||||||||||||||||||||||||
net gain on financial instruments at fair value through profit or loss | 17,297,000,000 | 354,535,000,000 | 2,537,000,000 | 27,984,000,000 | ||||||||||||||||||||||||||||||||||||||||
net foreign currency transaction gain | 366,000,000 | 27,525,000,000 | 41,756,000,000 | 32,204,000,000 | 4,150,000,000 | -5,432,000,000 | -31,416,000,000 | |||||||||||||||||||||||||||||||||||||
reversal of (benefit from) credit loss allowance | 73,000,000 | |||||||||||||||||||||||||||||||||||||||||||
general and administrative expense | -29,687,000,000 | 10,282,000,000 | ||||||||||||||||||||||||||||||||||||||||||
operating income | 2,503,975,000,000 | 5,059,246,000,000 | 1,706,640,000,000 | 1,424,182,000,000 | -8,613,000,000 | 1,329,369,000,000 | 1,276,422,000,000 | 1,368,021,000,000 | 1,248,697,000,000 | 728,485,000,000 | -44,078,000,000 | -43,054,000,000 | 1,018,325,000,000 | 1,797,396,000,000 | 652,932,000,000 | 580,996 | 1,296,178,000,000 | 118,485,000,000 | 2,013,010,000,000 | 323,890,000,000 | 791,007,000,000 | 686,294,000,000 | 937,182,000,000 | 1,820,863,000,000 | 498,694,000,000 | 304,689,500,000 | 407,338,000,000 | 364,948,000,000 | ||||||||||||||||
yoy | 4.11% | -100.69% | 82.48% | -2995.83% | -3277.45% | 22.62% | -59.47% | -106.59% | 175272191.03% | 38.67% | 451.07% | -100.00% | -63.42% | 154.49% | -82.21% | 58.62% | 125.24% | 130.07% | 398.94% | |||||||||||||||||||||||||
qoq | -16635.26% | -100.65% | 4.15% | -6.70% | 9.56% | 71.41% | -1752.72% | 2.38% | -104.23% | -43.34% | 112381396.60% | -100.00% | -94.11% | -59.05% | 15.26% | -26.77% | -48.53% | 265.13% | 63.67% | -25.20% | 11.62% | |||||||||||||||||||||||
non-operating income | -3,102,000,000 | -7,223,000,000 | 216,000,000 | 26,592,000,000 | 67 | 10,101,000,000 | 49,000,000 | 270,000,000 | 302,000,000 | 22,662,000,000 | 11,855,000,000 | 11,472,000,000 | ||||||||||||||||||||||||||||||||
profit before income taxes | 2,500,873,000,000 | 4,769,937,000,000 | 6,367 | 1,699,417,000,000 | 6,367 | 6,367 | 1,857 | 1,421,432,000,000 | -9,890,000,000 | 1,329,313,000,000 | 1,277,509,000,000 | 1,367,721,000,000 | 1,248,439,000,000 | -43,862,000,000 | -43,228,000,000 | 1,018,323,000,000 | ||||||||||||||||||||||||||||
income tax expense | 1,592,000,000 | 1,074,024,000,000 | 1,611 | 1,611 | 1,611 | 442 | 7,476,000,000 | 7,006,000,000 | 1,264,000,000 | 3,066,000,000 | -537,000,000 | -183,227,000,000 | -213,000,000 | 126,000,000 | -380,143,000,000 | 1,006,000,000 | ||||||||||||||||||||||||||||
other comprehensive income for the period, net of income taxitems that will not be reclassified to profit or loss: | ||||||||||||||||||||||||||||||||||||||||||||
remeasurements of the net defined benefit asset | ||||||||||||||||||||||||||||||||||||||||||||
total comprehensive income for the period | 2,499,281,000,000 | -16,896,000,000 | 1,328,049,000,000 | 1,364,977,000,000 | 1,248,976,000,000 | |||||||||||||||||||||||||||||||||||||||
basic and diluted earnings per share in won | 4,957 | 2,430 | 2,428 | 2,354 | 2,708 | 2,617 | ||||||||||||||||||||||||||||||||||||||
financial instruments at fair value through profit or loss | 697,467,000,000 | |||||||||||||||||||||||||||||||||||||||||||
financial instruments at fair value through other comprehensive income and amortized cost | 21,092,068,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net interest income | 8,837,037,000,000 | 10,597 | 10,597 | 10,597 | 2,574 | 1,565,288,000,000 | 4,367,133,000,000 | |||||||||||||||||||||||||||||||||||||
net foreign currencies transaction gain | 339,943,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net gain on financial instruments designated at fair value through profit or loss | -6,466,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net gain on disposal of securities at fair value through other comprehensive income | 101,135,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net income on disposal of securities at amortized cost | -41,000,000 | |||||||||||||||||||||||||||||||||||||||||||
benefit from credit loss allowance | 385,708,000,000 | -2,868,000,000 | -87,000,000 | -362,000,000 | ||||||||||||||||||||||||||||||||||||||||
general and administrative expenses | 3,913,170,000,000 | 5,644 | -135,853,000,000 | 5,644 | 5,644 | 1,356 | -118,851,000,000 | -29,168,000,000 | -26,047,000,000 | -103,095,000,000 | -22,571,000,000 | -23,293,000,000 | -18,489,000,000 | -16,077,000,000 | -15,173,000,000 | -2,918,011,000,000 | -12,118,000,000 | 18,608,000,000 | 23,631 | 71,147,000,000 | 9,540,000,000 | 46,673,000,000 | 46,673,000,000 | 15,740,000,000 | 13,510,000,000 | 15,464,000,000 | 14,814,000,000 | 47,138,000,000 | 250,721,000,000 | 9,799,000,000 | 23,902,000,000 | |||||||||||||
net other operating expenses | -1,369,718,000,000 | -505,118,000,000 | ||||||||||||||||||||||||||||||||||||||||||
net non-operating expenses | -299,165,000,000 | |||||||||||||||||||||||||||||||||||||||||||
share of profit of associates | 9,856,000,000 | |||||||||||||||||||||||||||||||||||||||||||
profit for the year | 3,695,913,000,000 | 1,671,011,000,000 | 1,413,956,000,000 | 1,274,443,000,000 | 515,413,000,000 | 1,455,653,000,000 | ||||||||||||||||||||||||||||||||||||||
(adjusted profit after reflection of regulatory reserve for loan loss | ||||||||||||||||||||||||||||||||||||||||||||
for the year ended december 31, 2024: | ||||||||||||||||||||||||||||||||||||||||||||
3,253,901 million won | ||||||||||||||||||||||||||||||||||||||||||||
for the year ended december 31, 2023: | ||||||||||||||||||||||||||||||||||||||||||||
3,219,679 million won | ||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income for the year, net of income tax | ||||||||||||||||||||||||||||||||||||||||||||
items that may be reclassified subsequently to profit or loss: | ||||||||||||||||||||||||||||||||||||||||||||
foreign currency translation differences for foreign operations | 4,926,000,000 | |||||||||||||||||||||||||||||||||||||||||||
unrealized net change in fair value of securities at fair value through other comprehensive income | ||||||||||||||||||||||||||||||||||||||||||||
shares in other comprehensive income of associates | ||||||||||||||||||||||||||||||||||||||||||||
items that will not be reclassified to profit or loss: | ||||||||||||||||||||||||||||||||||||||||||||
remeasurements of defined benefit plans | ||||||||||||||||||||||||||||||||||||||||||||
changes in own credit risk on financial liabilitiesdesignated at fair value through profit or loss | ||||||||||||||||||||||||||||||||||||||||||||
total comprehensive income for the year | 1,669,579,000,000 | 1,413,674,000,000 | 1,274,892,000,000 | 490,372,000,000 | ||||||||||||||||||||||||||||||||||||||||
profit attributable to: | ||||||||||||||||||||||||||||||||||||||||||||
equity holder of shinhan bank | ||||||||||||||||||||||||||||||||||||||||||||
non-controlling interests | 429,000,000 | |||||||||||||||||||||||||||||||||||||||||||
total comprehensive income attributable to: | ||||||||||||||||||||||||||||||||||||||||||||
equity holders of shinhan bank | ||||||||||||||||||||||||||||||||||||||||||||
earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||
net insurance income | 1,849 | 1,849 | 1,849 | -40 | ||||||||||||||||||||||||||||||||||||||||
insurance income | 3,629 | 3,629 | 3,629 | 712 | ||||||||||||||||||||||||||||||||||||||||
insurance expense | 1,780 | 1,780 | 1,780 | 752 | ||||||||||||||||||||||||||||||||||||||||
net gain on securities and fx trading/derivatives | -381 | -381 | -381 | 931 | ||||||||||||||||||||||||||||||||||||||||
benefit from credit loss and impairment loss | -1,318 | -1,318 | -1,318 | -461 | ||||||||||||||||||||||||||||||||||||||||
net other operating income | -1,616 | -1,616 | -1,616 | -496 | ||||||||||||||||||||||||||||||||||||||||
net operating income | 5,906 | 5,906 | 5,906 | 1,756 | ||||||||||||||||||||||||||||||||||||||||
equity method income | 122 | 122 | 122 | 45 | ||||||||||||||||||||||||||||||||||||||||
other non-operating income | 339 | 339 | 339 | 56 | ||||||||||||||||||||||||||||||||||||||||
consolidated net profit | 4,756 | 4,756 | 4,756 | 1,414 | ||||||||||||||||||||||||||||||||||||||||
net profit attributable to equity holders of the group | 4,666 | 4,666 | 4,666 | 1,388 | ||||||||||||||||||||||||||||||||||||||||
net profit attributable to non-controlling interest | 90 | 90 | 90 | 26 | ||||||||||||||||||||||||||||||||||||||||
1) based on the financial holding company business report submitted to the fss2) fiscal year 2022 has been restated retrospectively to reflect newly applied k-ifrs no.1117 ‘insurance contract’ from 2023. fiscal year 2021 has not been restated. | ||||||||||||||||||||||||||||||||||||||||||||
consolidated basis | 1 | |||||||||||||||||||||||||||||||||||||||||||
1) fiscal year 2022 has been restated retrospectively to reflect newly applied k-ifrs no.1117 ‘insurance contract’ from 2023. fiscal year 2021 has not been restated. | ||||||||||||||||||||||||||||||||||||||||||||
financial assets at amortized cost | 93,504,000,000 | 75,085,000,000 | 19,375,000,000 | 16,969,000,000 | 69,119,000,000 | 13,351,000,000 | 11,962,000,000 | 1,987,231,000,000 | ||||||||||||||||||||||||||||||||||||
net gain on financial assets at fair value through profit or loss | 151,698,000,000 | 722,000,000 | 2,338,000,000 | 91,665,000,000 | 4,577,000,000 | |||||||||||||||||||||||||||||||||||||||
reversal of credit loss allowance | 1,363,000,000 | -701,000,000 | ||||||||||||||||||||||||||||||||||||||||||
income tax benefit | 28,406,000,000 | 2,744,000,000 | 270,000,000 | |||||||||||||||||||||||||||||||||||||||||
items that will not be reclassified subsequently to profit or loss: re-measurements of the defined benefit asset | -1,432,000,000 | |||||||||||||||||||||||||||||||||||||||||||
basic and diluted earnings per share in korean won | 2,853 | -101 | ||||||||||||||||||||||||||||||||||||||||||
1) some of the totals may not sum due to rounding.2) fiscal year 2022 has been restated retrospectively to reflect newly applied k-ifrs no.1117 ‘insurance contract’ from 2023. fiscal year 2021 has not been restated. | ||||||||||||||||||||||||||||||||||||||||||||
1) some of the totals may not sum due to rounding.2) fiscal year 2022 has been restated retrospectively to reflect newly applied k-ifrs no.1117 ‘insurance contract’ from 2023. | ||||||||||||||||||||||||||||||||||||||||||||
other operating income | 6,944,000,000 | 2,334,000,000 | -515,000,000 | |||||||||||||||||||||||||||||||||||||||||
non-operating expense | -2,750,000,000 | -1,277,000,000 | -56,000,000 | 1,087,000,000 | -300,000,000 | -258,000,000 | -25,252,000,000 | -174,000,000 | -2,000,000 | |||||||||||||||||||||||||||||||||||
items that will not be reclassified subsequently to profit or loss: re-measurements of the defined benefit liability | -282,000,000 | |||||||||||||||||||||||||||||||||||||||||||
other comprehensive income for the period, net of income tax | ||||||||||||||||||||||||||||||||||||||||||||
items that will not be reclassified subsequently to profit or loss re-measurements of the defined benefit liability | -153,000,000 | |||||||||||||||||||||||||||||||||||||||||||
items that will never be reclassified to profit or loss : re-measurements of the defined benefit liability | 449,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net foreign currency transaction loss | 7,299,000,000 | 8,613,000,000 | ||||||||||||||||||||||||||||||||||||||||||
provision (reversal) for credit loss allowance | -643,000,000 | |||||||||||||||||||||||||||||||||||||||||||
provision for credit loss allowance | 190,000,000 | -469,362,000,000 | ||||||||||||||||||||||||||||||||||||||||||
loans and receivables | ||||||||||||||||||||||||||||||||||||||||||||
fee and commission income | 1,484,645,000,000 | |||||||||||||||||||||||||||||||||||||||||||
fee and commission income before k-ifrs no.1115 | 2,620,085,000,000 | |||||||||||||||||||||||||||||||||||||||||||
consideration paid to customers | -1,135,440,000,000 | |||||||||||||||||||||||||||||||||||||||||||
fee and commission expense | -1,252,098,000,000 | |||||||||||||||||||||||||||||||||||||||||||
fee and commission expense before k-ifrs no.1115 | -2,387,538,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net fee and commission income | 232,547,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net income on trading financial assets | ||||||||||||||||||||||||||||||||||||||||||||
net income on financial assets at fair value through profit or loss | 55,567,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net income on derivatives | 4,670,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net income on foreign currency transactions | 31,050,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net gain on sales of available-for-sale financial assets | ||||||||||||||||||||||||||||||||||||||||||||
net impairment loss on financial assets | ||||||||||||||||||||||||||||||||||||||||||||
general administrative expenses | -692,153,000,000 | |||||||||||||||||||||||||||||||||||||||||||
impairment loss on investments in associates | -4,593,000,000 | |||||||||||||||||||||||||||||||||||||||||||
profit before income tax | 698,640,000,000 | 1,835,796,000,000 | ||||||||||||||||||||||||||||||||||||||||||
other comprehensive income : | ||||||||||||||||||||||||||||||||||||||||||||
items that will never be reclassified to profit or loss | ||||||||||||||||||||||||||||||||||||||||||||
remeasurement of the net defined benefit obligations | -10,481,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net changes in the unrealized fair value of financial assets at fair value through other comprehensive income | 2,385,000,000 | |||||||||||||||||||||||||||||||||||||||||||
items that are or may be reclassified subsequently to profit or loss | ||||||||||||||||||||||||||||||||||||||||||||
net changes in the unrealized fair value of available-for-sale financial assets | ||||||||||||||||||||||||||||||||||||||||||||
net changes in the unrealized fair value of cash flow hedges | -16,945,000,000 | |||||||||||||||||||||||||||||||||||||||||||
earnings per share basic and diluted earnings per share | 4,111 | |||||||||||||||||||||||||||||||||||||||||||
net trading income | 1,052,000,000 | 3,724,000,000 | 1,075,000,000 | 16,446,000,000 | ||||||||||||||||||||||||||||||||||||||||
reversal of (provision for) credit losses | -41,000,000 | 52,000,000 | 8,000,000 | -15,000,000 | ||||||||||||||||||||||||||||||||||||||||
other comprehensive loss for the period, net of income tax | ||||||||||||||||||||||||||||||||||||||||||||
items that will never be reclassified to profit or loss : | ||||||||||||||||||||||||||||||||||||||||||||
remeasurements of the defined benefit plans | ||||||||||||||||||||||||||||||||||||||||||||
items that will never be reclassified to profit or loss: | ||||||||||||||||||||||||||||||||||||||||||||
remeasurements of the defined benefit liabilities | 209,000,000 | |||||||||||||||||||||||||||||||||||||||||||
earnings per share | ||||||||||||||||||||||||||||||||||||||||||||
net trading loss | -39,804,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net foreign currencies transactions gain | 252,759,000,000 | |||||||||||||||||||||||||||||||||||||||||||
gain on financial instruments designated at fair value through profit or loss | 34,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net gain on sale of available-for-sale financial assets | 427,992,000,000 | |||||||||||||||||||||||||||||||||||||||||||
impairment loss on financial assets | -684,010,000,000 | |||||||||||||||||||||||||||||||||||||||||||
equity in income of investments in associate | 11,808,000,000 | |||||||||||||||||||||||||||||||||||||||||||
other comprehensive income: | ||||||||||||||||||||||||||||||||||||||||||||
unrealized net change in fair value of available-for-sale financial assets | 63,811,000,000 | |||||||||||||||||||||||||||||||||||||||||||
items that will never be reclassified subsequently to profit or loss | ||||||||||||||||||||||||||||||||||||||||||||
defined benefit plan actuarial gain | -131,907,000,000 | |||||||||||||||||||||||||||||||||||||||||||
other comprehensive loss for the year, net of income tax | -58,873,000,000 | |||||||||||||||||||||||||||||||||||||||||||
other operating income (expenses) | 32,226,000,000 | |||||||||||||||||||||||||||||||||||||||||||
income before income taxes | -28,068,000,000 | 653,008,000,000 | 581,063 | 1,306,279,000,000 | 118,465,000,000 | 2,013,975,000,000 | 323,939,000,000 | 791,277,000,000 | 686,596,000,000 | 959,844,000,000 | 1,832,718,000,000 | 304,883,250,000 | 407,391,000,000 | |||||||||||||||||||||||||||||||
net income for the period | -29,074,000,000 | |||||||||||||||||||||||||||||||||||||||||||
other comprehensive income for the period | ||||||||||||||||||||||||||||||||||||||||||||
cash flow hedges | 569,000,000 | |||||||||||||||||||||||||||||||||||||||||||
income tax effect | -138,000,000 | |||||||||||||||||||||||||||||||||||||||||||
basic earnings per share in won | ||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share in won | ||||||||||||||||||||||||||||||||||||||||||||
operating revenue | ||||||||||||||||||||||||||||||||||||||||||||
equity in income of equity method accounted investees | ||||||||||||||||||||||||||||||||||||||||||||
royalty | 30,321,000,000 | 26,619 | 136,025,000,000 | 136,025,000,000 | 33,993,000,000 | 135,771,000,000 | 135,771,000,000 | 33,852,000,000 | 67,775,000,000 | |||||||||||||||||||||||||||||||||||
other | 726,000,000 | 23,501 | 14,793,000,000 | 582,000,000 | 996,000,000 | 999,000,000 | 396,000,000 | 1,495,000,000 | 332,029,000,000 | 148,000,000 | -797,000,000 | |||||||||||||||||||||||||||||||||
operating expense | ||||||||||||||||||||||||||||||||||||||||||||
equity in loss of equity method accounted investees | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||
fees and commission | 19,000,000 | 39 | 340,000,000 | 33,000,000 | 291,000,000 | 291,000,000 | 16,000,000 | 30,000,000 | 77,000,000 | 19,000,000 | 269,000,000 | 20,250,000 | 15,000,000 | 4,962,000,000 | ||||||||||||||||||||||||||||||
non-operating income(expenses) | 76,000,000 | 965,000,000 | ||||||||||||||||||||||||||||||||||||||||||
income tax expenses | 1,024,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net income | 304,883,250,000 | |||||||||||||||||||||||||||||||||||||||||||
yoy | ||||||||||||||||||||||||||||||||||||||||||||
qoq | ||||||||||||||||||||||||||||||||||||||||||||
(in millions of won, | ||||||||||||||||||||||||||||||||||||||||||||
except earnings per share) | ||||||||||||||||||||||||||||||||||||||||||||
gain from equity method investees | ||||||||||||||||||||||||||||||||||||||||||||
income from equity method investees | 7 | |||||||||||||||||||||||||||||||||||||||||||
income tax benefits | 2,486 | 13,000,000 | 13,000,000 | 6,423,000,000 | ||||||||||||||||||||||||||||||||||||||||
gain from equity method accounted investments | 1,511,064,000,000 | |||||||||||||||||||||||||||||||||||||||||||
loss from equity method accounted investments | 244,000,000 | 244,000,000 | ||||||||||||||||||||||||||||||||||||||||||
operating expense - sum | 504,176,000,000 | |||||||||||||||||||||||||||||||||||||||||||
earning per share in won | ||||||||||||||||||||||||||||||||||||||||||||
i. operating revenues | 1,800,354,000,000 | 2,455,917,000,000 | ||||||||||||||||||||||||||||||||||||||||||
1. interest on due from banks | 18,584,000,000 | 18,589,000,000 | ||||||||||||||||||||||||||||||||||||||||||
2. interest on loans | 119,888,000,000 | 116,914,000,000 | ||||||||||||||||||||||||||||||||||||||||||
gain on foreign currency transaction | 10,818,000,000 | 657,000,000 | 749,000,000 | |||||||||||||||||||||||||||||||||||||||||
reversal of allowance for possible loan losses | 3,975,000,000 | |||||||||||||||||||||||||||||||||||||||||||
ii. operating expenses | 504,176,000,000 | 442,907,000,000 | ||||||||||||||||||||||||||||||||||||||||||
interest expenses | 421,627,000,000 | 390,602,000,000 | ||||||||||||||||||||||||||||||||||||||||||
1. interest on borrowings | 64,518,000,000 | 32,402,000,000 | ||||||||||||||||||||||||||||||||||||||||||
2. interest on debentures | 357,109,000,000 | 358,200,000,000 | ||||||||||||||||||||||||||||||||||||||||||
loss on foreign currency transaction | 13,000,000 | |||||||||||||||||||||||||||||||||||||||||||
commission expenses | 340,000,000 | |||||||||||||||||||||||||||||||||||||||||||
administrative expenses | 71,147,000,000 | |||||||||||||||||||||||||||||||||||||||||||
1. salaries | 26,479,000,000 | 3,857,000,000 | ||||||||||||||||||||||||||||||||||||||||||
2. retirement benefits | 1,425,000,000 | |||||||||||||||||||||||||||||||||||||||||||
3. employee benefits | 1,797,000,000 | 1,545,000,000 | ||||||||||||||||||||||||||||||||||||||||||
4. rent | 1,164,000,000 | 1,085,000,000 | ||||||||||||||||||||||||||||||||||||||||||
5. entertainment | 1,387,000,000 | 918,000,000 | ||||||||||||||||||||||||||||||||||||||||||
6. depreciation | 460,000,000 | 514,000,000 | ||||||||||||||||||||||||||||||||||||||||||
7. amortization on intangible assets | 433,000,000 | 297,000,000 | ||||||||||||||||||||||||||||||||||||||||||
8. bad debt expense | 5,151,000,000 | |||||||||||||||||||||||||||||||||||||||||||
9. taxes and dues | 609,000,000 | 439,000,000 | ||||||||||||||||||||||||||||||||||||||||||
10. advertising | 18,788,000,000 | 15,168,000,000 | ||||||||||||||||||||||||||||||||||||||||||
11.commissions | 15,570,000,000 | 14,422,000,000 | ||||||||||||||||||||||||||||||||||||||||||
12. other expenses | 3,035,000,000 | 2,645,000,000 | ||||||||||||||||||||||||||||||||||||||||||
loss on derivatives | 10,818,000,000 | |||||||||||||||||||||||||||||||||||||||||||
iii. operating income | 1,296,178,000,000 | 2,013,010,000,000 | ||||||||||||||||||||||||||||||||||||||||||
iv. non-operating income | 11,131,000,000 | 999,000,000 | ||||||||||||||||||||||||||||||||||||||||||
gain on disposition of equity method accounted investments | 10,509,000,000 | |||||||||||||||||||||||||||||||||||||||||||
gain on sale of premises and equipment | 40,000,000 | |||||||||||||||||||||||||||||||||||||||||||
v. non-operating expenses | 1,030,000,000 | 34,000,000 | ||||||||||||||||||||||||||||||||||||||||||
loss on sale of premises and equipment | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||
contribution | 631,000,000 | 34,000,000 | ||||||||||||||||||||||||||||||||||||||||||
vi. income before income tax expenses | 1,306,279,000,000 | 2,013,975,000,000 | ||||||||||||||||||||||||||||||||||||||||||
vii. income tax benefits | -13,000,000 | 6,423,000,000 | ||||||||||||||||||||||||||||||||||||||||||
viii. net income for year | 1,306,292,000,000 | 2,020,398,000,000 | ||||||||||||||||||||||||||||||||||||||||||
ix. earning per share | ||||||||||||||||||||||||||||||||||||||||||||
basic earnings per share | ||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share | ||||||||||||||||||||||||||||||||||||||||||||
operating revenue: | ||||||||||||||||||||||||||||||||||||||||||||
gain from equity method investment securities | ||||||||||||||||||||||||||||||||||||||||||||
operating expense: | ||||||||||||||||||||||||||||||||||||||||||||
loss from equity method investment securities | ||||||||||||||||||||||||||||||||||||||||||||
operating expense: - sum | 126,237,000,000 | 105,349,000,000 | 45,620,000,000 | 121,480,000,000 | ||||||||||||||||||||||||||||||||||||||||
non-operating expenses | -20,000,000 | |||||||||||||||||||||||||||||||||||||||||||
earnings per share in won and u.s. dollars | ||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share in won and u.s. dollars | ||||||||||||||||||||||||||||||||||||||||||||
income from equity method investment securities | 5,328,000,000 | 4,979,000,000 | ||||||||||||||||||||||||||||||||||||||||||
income from foreign currency transaction | 13,000,000 | 657,000,000 | 749,000,000 | |||||||||||||||||||||||||||||||||||||||||
gain using equity method of accounting | 2,184,643,000,000 | |||||||||||||||||||||||||||||||||||||||||||
loss using equity method of accounting | 5,328,000,000 | |||||||||||||||||||||||||||||||||||||||||||
2. retirement allowance | 632,000,000 | |||||||||||||||||||||||||||||||||||||||||||
gain on sale of tangible assets | ||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per shares | ||||||||||||||||||||||||||||||||||||||||||||
equity from earnings of equity method investment securities | ||||||||||||||||||||||||||||||||||||||||||||
equity from loss of equity method investment securities | 23,195,000,000 | 1,733,000,000 | ||||||||||||||||||||||||||||||||||||||||||
loss from foreign currency transaction | ||||||||||||||||||||||||||||||||||||||||||||
income taxes | ||||||||||||||||||||||||||||||||||||||||||||
total operating revenue | 1,015,411,000,000 | 1,997,914,000,000 | ||||||||||||||||||||||||||||||||||||||||||
total operating expense | 78,229,000,000 | 177,051,000,000 | ||||||||||||||||||||||||||||||||||||||||||
gain from equity method | 314,137,750,000 | |||||||||||||||||||||||||||||||||||||||||||
loss from equity method | 601,000,000 | 273,000,000 | 327,000,000 | |||||||||||||||||||||||||||||||||||||||||
income per share in won and u.s. dollars | ||||||||||||||||||||||||||||||||||||||||||||
diluted income per share in won and u.s. dollars | ||||||||||||||||||||||||||||||||||||||||||||
operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||
operating expenses: - sum | 27,162,000,000 | 38,995,000,000 | ||||||||||||||||||||||||||||||||||||||||||
non-operating income (expenses) | 193,750,000 | 53,000,000 | ||||||||||||||||||||||||||||||||||||||||||
ordinary income and net earnings per share in won and u.s. dollars | 0.915 | 952 | ||||||||||||||||||||||||||||||||||||||||||
diluted ordinary income and net earnings per share in won and u.s. dollars | 0.808 | 921 | ||||||||||||||||||||||||||||||||||||||||||
valuation gain using the equity method | ||||||||||||||||||||||||||||||||||||||||||||
non-operating income: | ||||||||||||||||||||||||||||||||||||||||||||
gain from sale of investment securities accounted for by the equity method | -166,000,000 | |||||||||||||||||||||||||||||||||||||||||||
loss from sale of available-for-sale securities | -1,725,000,000 | |||||||||||||||||||||||||||||||||||||||||||
gain on foreign currency transactions | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||
donation | -34,000,000 | |||||||||||||||||||||||||||||||||||||||||||
non-operating income: - sum | -2,721,000,000 | |||||||||||||||||||||||||||||||||||||||||||
earnings before income taxes | 362,227,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net earnings |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-11-14 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-03-31 | 2024-03-04 | 2023-09-30 | 2023-03-04 | 2019-05-21 | 2019-03-11 | 2017-11-14 | 2015-08-17 | 2015-05-15 | 2015-03-10 | 2010-11-15 | 2010-08-16 | 2010-03-31 | 2010-02-26 | 2009-05-15 | 2009-03-31 | 2009-02-19 | 2008-12-31 | 2008-11-14 | 2008-03-31 | 2008-02-22 | 2007-08-14 | 2007-05-15 | 2006-04-02 | 2006-02-21 | 2004-04-13 | 2003-12-31 | 2002-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||
cash and due from banks at amortized cost | 337,663,000,000 | 337,663,000,000 | 16,000,000 | 376,612,000,000 | 2,349,000,000 | 72,000,000 | 35,888,889,000,000 | 22,000,000 | 21,882,775,000,000 | ||||||||||||||||||||||||
financial assets at fair value through profit or loss | 3,506,010,000,000 | 3,506,010,000,000 | 3,632,919,000,000 | 4,596,273,000,000 | 3,037,400,000,000 | 4,149,843,000,000 | 606,717,000,000 | 66,712,929,000,000 | 1,985,760,000,000 | 47,790,320,000,000 | 953,943,000,000 | ||||||||||||||||||||||
loans at amortized cost | 3,028,215,000,000 | 3,028,215,000,000 | 2,984,674,000,000 | 3,314,502,000,000 | 3,864,007,000,000 | 4,166,584,000,000 | 411,354,717,000,000 | 4,051,004,000,000 | 307,959,580,000,000 | ||||||||||||||||||||||||
property and equipment | 5,431,000,000 | 5,431,000,000 | 6,242,000,000 | 6,473,000,000 | 7,579,000,000 | 9,582,000,000 | 645,716,000,000 | 3,952,753,000,000 | 7,586,000,000 | 3,625,836,000,000 | 87,649,000,000 | 2,987,458,000,000 | 3,012,579,000,000 | 3,114,557,000,000 | 2,036,119,000,000 | 1,481,000,000 | 1,638,000,000 | 2,323,874,000,000 | 1,374,000,000 | 1,191,000,000 | 2,411,000,000,000 | 1,615,000,000 | 1,473,000,000 | 701,000,000 | 693,000,000 | ||||||||
intangible assets | 7,240,000,000 | 7,240,000,000 | 6,844,000,000 | 6,642,000,000 | 6,074,000,000 | 6,755,000,000 | 228,428,000,000 | 6,235,855,000,000 | 7,745,000,000 | 5,624,571,000,000 | 44,967,000,000 | 4,224,124,000,000 | 4,220,335,000,000 | 4,244,863,000,000 | 180,267,000,000 | 1,173,551,000,000 | |||||||||||||||||
investments in subsidiaries | 30,723,705,000,000 | 30,723,705,000,000 | 30,723,705,000,000 | 30,723,705,000,000 | 30,593,155,000,000 | 30,723,087,000,000 | 30,723,087,000,000 | ||||||||||||||||||||||||||
net defined benefit assets | 766,000,000 | 2,598,000,000 | 5,011,000,000 | 311,933,000,000 | 7,077,000,000 | ||||||||||||||||||||||||||||
deferred tax assets | 6,813,000,000 | 6,813,000,000 | 131,277,000,000 | 144,160,000,000 | 248,692,000,000 | 218,911,000,000 | 497,761,000,000 | 195,252,000,000 | 173,180,000,000 | 90,575,000,000 | |||||||||||||||||||||||
other assets | 807,900,000,000 | 807,900,000,000 | 623,737,000,000 | 618,850,000,000 | 637,251,000,000 | 679,561,000,000 | 1,057,480,000,000 | 34,096,203,000,000 | 507,274,000,000 | 32,317,829,000,000 | 1,055,391,000,000 | 23,060,043,000,000 | 21,083,982,000,000 | 18,245,860,000,000 | 8,190,271,000,000 | 296,805,000,000 | 334,000,000,000 | 14,508,732,000,000 | 72,338,000,000 | 86,589,000,000 | 26,167,000,000,000 | 107,680,000,000 | 108,746,000,000 | 55,973,000,000 | 83,587,000,000 | 578,345,000,000 | 4,601,724,000,000 | 1,648,000,000,000 | |||||
total assets | 38,422,977,000,000 | 38,422,977,000,000 | 37,978,137,000,000 | 39,643,823,000,000 | 38,147,815,000,000 | 39,738,082,000,000 | 44,137,094,000,000 | 690,013,268,000,000 | 37,289,555,000,000 | 513,865,397,000,000 | 29,350,065,000,000 | 27,120,706,000,000 | 25,913,566,000,000 | 264,015,000,000,000 | 25,327,528,000,000 | 67,395,133,000,000 | |||||||||||||||||
liabilities | |||||||||||||||||||||||||||||||||
borrowings | 9,899,000,000 | 9,899,000,000 | 9,823,000,000 | 9,748,000,000 | 19,865,000,000 | 169,488,000,000 | 6,550,378,000,000 | 55,806,051,000,000 | 223,722,000,000 | 29,274,787,000,000 | 4,910,631,000,000 | 29,420,507,000,000 | 24,974,958,000,000 | 23,876,928,000,000 | 12,802,821,000,000 | 18,097,872,000,000 | 27,731,000,000,000 | ||||||||||||||||
debt securities issued | 10,517,579,000,000 | 10,517,579,000,000 | 9,576,232,000,000 | 10,045,455,000,000 | 10,525,669,000,000 | 10,845,299,000,000 | 77,181,740,000,000 | 10,389,276,000,000 | 67,263,045,000,000 | 49,572,020,000,000 | 39,270,034,000,000 | 38,506,393,000,000 | 16,581,408,000,000 | ||||||||||||||||||||
net defined benefit liabilities | 2,377,000,000 | 2,377,000,000 | 2,523,000,000 | 433,000,000 | 52,195,000,000 | ||||||||||||||||||||||||||||
deferred tax liabilities | 18,852,000,000 | 21,174,000,000 | 17,400,000,000 | 11,109,000,000 | 665,832,000,000 | 9,589,000,000 | 353,908,000,000 | 7,461,000,000 | 10,359,000,000 | 12,674,000,000 | 9,335,000,000 | ||||||||||||||||||||||
other liabilities | 849,040,000,000 | 849,040,000,000 | 669,322,000,000 | 907,763,000,000 | 682,704,000,000 | 895,827,000,000 | 4,603,613,000,000 | 50,665,379,000,000 | 567,827,000,000 | 40,565,867,000,000 | 3,944,127,000,000 | 30,383,454,000,000 | 27,965,392,000,000 | 25,369,929,000,000 | 13,729,078,000,000 | 316,154,000,000 | 330,436,000,000 | 27,978,208,000,000 | 55,691,000,000 | 123,586,000,000 | 42,006,000,000,000 | 126,526,000,000 | 73,089,000,000 | 54,537,000,000 | 420,328,000,000 | 34,424,000,000 | |||||||
total liabilities | 11,378,895,000,000 | 11,378,895,000,000 | 10,276,752,000,000 | 10,984,140,000,000 | 11,246,071,000,000 | 11,921,723,000,000 | 35,860,198,000,000 | 633,596,642,000,000 | 11,190,414,000,000 | 475,270,984,000,000 | 23,311,374,000,000 | 396,104,856,000,000 | 328,418,754,000,000 | 317,100,512,000,000 | 235,169,429,000,000 | 6,648,620,000,000 | 6,383,670,000,000 | 233,895,061,000,000 | 6,392,345,000,000 | 7,722,359,000,000 | 6,392,345,000,000 | 8,307,683,000,000 | 246,063,000,000,000 | 7,226,602,000,000 | 8,307,683,000,000 | 7,349,727,000,000 | 7,287,244,000,000 | 6,228,730,000,000 | 3,642,105,000,000 | 65,240,936,000,000 | 131,660,154,000,000 | 61,236,000,000,000 | |
equity | |||||||||||||||||||||||||||||||||
capital stock | 2,969,641,000,000 | 2,969,641,000,000 | 2,969,641,000,000 | 2,969,641,000,000 | 2,969,641,000,000 | 2,969,641,000,000 | 2,969,641,000,000 | 2,969,641,000,000 | 2,645,053,000,000 | 2,645,053,000,000 | 2,645,053,000,000 | 2,645,053,000,000 | 7,928,078,000,000 | ||||||||||||||||||||
hybrid bonds | 4,749,837,000,000 | 4,749,837,000,000 | 4,799,501,000,000 | 4,998,956,000,000 | 4,600,121,000,000 | 4,400,564,000,000 | 699,822,000,000 | 4,001,731,000,000 | 4,001,731,000,000 | 1,531,759,000,000 | 423,921,000,000 | 736,898,000,000 | 537,443,000,000 | 1,100,250,000,000 | |||||||||||||||||||
capital surplus | 11,350,744,000,000 | 11,350,744,000,000 | 11,350,744,000,000 | 11,350,744,000,000 | 11,350,744,000,000 | 11,350,744,000,000 | 860,729,000,000 | 12,094,968,000,000 | 11,350,744,000,000 | 9,904,973,000,000 | 860,592,000,000 | 9,887,335,000,000 | 9,887,335,000,000 | 9,887,335,000,000 | 403,164,000,000 | 9,924,852,000,000 | 9,924,852,000,000 | 9,924,852,000,000 | 9,918,032,000,000 | 9,924,852,000,000 | 9,032,572,000,000 | 9,032,572,000,000 | 7,877,765,000,000 | 7,877,765,000,000 | 4,360,082,000,000 | ||||||||
capital adjustments | -311,285,000,000 | -311,285,000,000 | -46,045,000,000 | -571,760,000,000 | -346,151,000,000 | -45,797,000,000 | -2,354,000,000 | -658,470,000,000 | -148,464,000,000 | -563,656,000,000 | 1,234,000,000 | -398,004,000,000 | -423,577,000,000 | -422,993,000,000 | -842,000,000 | -417,192,000,000 | -417,192,000,000 | -417,142,000,000 | -417,829,000,000 | -417,142,000,000 | -424,527,000,000 | -432,887,000,000 | 53,853,000,000 | 1,442,726,000,000 | |||||||||
accumulated other comprehensive loss | -11,375,000,000 | -11,375,000,000 | -11,375,000,000 | -9,307,000,000 | -8,179,000,000 | -6,642,000,000 | -79,023,000,000 | -1,043,520,000,000 | -6,642,000,000 | -454,320,000,000 | -347,043,000,000 | ||||||||||||||||||||||
retained earnings | 8,296,520,000,000 | 8,296,520,000,000 | 8,638,919,000,000 | 9,921,409,000,000 | 8,335,568,000,000 | 9,147,849,000,000 | 6,147,734,000,000 | 36,251,890,000,000 | 7,932,131,000,000 | 23,099,585,000,000 | 4,579,396,000,000 | 20,583,744,000,000 | 16,625,488,000,000 | 15,941,067,000,000 | 10,805,574,000,000 | 8,591,992,000,000 | 8,124,282,000,000 | 7,182,853,000,000 | 6,178,774,000,000 | 7,185,605,000,000 | 6,009,528,000,000 | 6,301,394,000,000 | 4,642,396,000,000 | 3,956,407,000,000 | 3,387,960,000,000 | 1,188,688,000,000 | 1,077,000,000,000 | ||||||
total equity | 27,044,082,000,000 | 27,044,082,000,000 | 27,701,385,000,000 | 28,659,683,000,000 | 26,901,744,000,000 | 27,816,359,000,000 | 8,276,896,000,000 | 56,416,626,000,000 | 26,099,141,000,000 | 38,594,413,000,000 | 6,038,691,000,000 | 33,687,797,000,000 | 31,008,475,000,000 | 30,307,727,000,000 | 20,476,900,000,000 | ||||||||||||||||||
total liabilities and equity | 38,422,977,000,000 | 38,422,977,000,000 | 37,978,137,000,000 | 39,643,823,000,000 | 38,147,815,000,000 | 39,738,082,000,000 | 44,137,094,000,000 | 690,013,268,000,000 | 37,289,555,000,000 | 513,865,397,000,000 | 29,350,065,000,000 | ||||||||||||||||||||||
cash and due from banks | 864,692,000,000 | 341,217,000,000 | |||||||||||||||||||||||||||||||
derivative assets | 670,186,000,000 | 6,235,318,000,000 | 2,255,856,000,000 | 310,000,000 | 1,891,093,000,000 | 1,661,667,000,000 | 1,650,876,000,000 | 1,309,094,000,000 | |||||||||||||||||||||||||
credit card receivables at amortized cost and others | 37,267,649,000,000 | ||||||||||||||||||||||||||||||||
lease assets | 2,133,859,000,000 | 365,581,000,000 | |||||||||||||||||||||||||||||||
financial assets at fair value through othercomprehensive income | 378,530,000,000 | ||||||||||||||||||||||||||||||||
investments in associates | 101,903,000,000 | 3,039,628,000,000 | 694,235,000,000 | 34,060,000,000 | 596,936,000,000 | 370,008,000,000 | 350,682,000,000 | 211,272,000,000 | |||||||||||||||||||||||||
current tax assets | 4,000,000 | 7,033,000,000 | |||||||||||||||||||||||||||||||
investment property | 45,642,000,000 | 263,810,000,000 | 483,039,000,000 | 438,506,000,000 | 231,303,000,000 | 269,807,000,000 | |||||||||||||||||||||||||||
derivative liabilities | 6,100,000,000 | 7,291,988,000,000 | 2,273,782,000,000 | 23,293,000,000 | 2,052,659,000,000 | 1,930,346,000,000 | 1,691,108,000,000 | 1,256,438,000,000 | |||||||||||||||||||||||||
debentures | 24,409,874,000,000 | 14,143,288,000,000 | 39,904,757,000,000 | 6,559,759,000,000 | 49,181,000,000,000 | 6,688,309,000,000 | 7,078,333,000,000 | 5,896,694,000,000 | 5,088,504,000,000 | 3,421,826,000,000 | |||||||||||||||||||||||
net defined benefit obligations | 173,000,000 | ||||||||||||||||||||||||||||||||
current tax liabilities | 69,112,000,000 | 89,623,000,000 | 170,699,000,000 | ||||||||||||||||||||||||||||||
provisions | 220,948,000,000 | 1,009,204,000,000 | 539,301,000,000 | 182,477,000,000 | 441,776,000,000 | 698,508,000,000 | 652,946,000,000 | 298,728,000,000 | |||||||||||||||||||||||||
common stock | 626,847,000,000 | 2,370,998,000,000 | 2,370,998,000,000 | 2,370,998,000,000 | 2,370,998,000,000 | 2,370,998,000,000 | 1,980,998,000,000 | 1,980,998,000,000 | 1,907,838,000,000 | 1,907,838,000,000 | 1,907,838,000,000 | 1,472,007,000,000 | 1,462,000,000,000 | ||||||||||||||||||||
equity attributable to owner of the company | 8,253,755,000,000 | ||||||||||||||||||||||||||||||||
non-controlling interests | 23,141,000,000 | 2,800,386,000,000 | 2,431,019,000,000 | 892,791,000,000 | 1,027,154,000,000 | 1,024,995,000,000 | 3,277,000,000 | ||||||||||||||||||||||||||
securities at fair value through other comprehensive income | 86,388,117,000,000 | 50,757,646,000,000 | |||||||||||||||||||||||||||||||
securities at amortized cost | 35,238,498,000,000 | 40,144,111,000,000 | |||||||||||||||||||||||||||||||
current tax receivable | 31,623,000,000 | 72,841,000,000 | 17,107,000,000 | 4,681,000,000 | 15,195,000,000 | ||||||||||||||||||||||||||||
insurance contract assets | 3,373,000,000 | ||||||||||||||||||||||||||||||||
reinsurance contract assets | 79,352,000,000 | ||||||||||||||||||||||||||||||||
assets held for sale | 36,110,000,000 | 8,066,000,000 | 14,918,000,000 | 314,527,000,000 | 5,624,000,000 | ||||||||||||||||||||||||||||
deposits | 384,994,956,000,000 | 273,848,328,000,000 | 189,639,872,000,000 | 126,764,000,000,000 | |||||||||||||||||||||||||||||
financial liabilities at fair value through profit or loss | 1,731,737,000,000 | 2,108,984,000,000 | |||||||||||||||||||||||||||||||
financial liabilities designated at fair value through profit or loss | 7,187,642,000,000 | 8,727,229,000,000 | 9,085,015,000,000 | 9,678,199,000,000 | 9,604,918,000,000 | ||||||||||||||||||||||||||||
current tax payable | 327,513,000,000 | 509,556,000,000 | 407,853,000,000 | 208,720,000,000 | 326,568,000,000 | ||||||||||||||||||||||||||||
insurance contract liabilities | 44,448,225,000,000 | ||||||||||||||||||||||||||||||||
reinsurance contract liabilities | 68,073,000,000 | ||||||||||||||||||||||||||||||||
investment contract liabilities | 2,166,107,000,000 | ||||||||||||||||||||||||||||||||
total equity attributable to equity holders of shinhan financial group co., ltd. | 53,616,240,000,000 | 36,163,394,000,000 | 32,795,006,000,000 | 29,981,321,000,000 | |||||||||||||||||||||||||||||
liabilities for defined benefit obligations | 147,564,000,000 | 168,233,000,000 | 368,491,000,000 | 314,180,000,000 | |||||||||||||||||||||||||||||
liabilities under insurance contracts | 49,658,633,000,000 | 24,009,176,000,000 | 18,906,054,000,000 | 18,354,395,000,000 | |||||||||||||||||||||||||||||
trading financial assets | |||||||||||||||||||||||||||||||||
loans and receivables | |||||||||||||||||||||||||||||||||
credit card assets at amortized cost, etc. | 26,213,517,000,000 | ||||||||||||||||||||||||||||||||
available-for-sale financial assets | 41,013,575,000,000 | 31,340,670,000,000 | 30,576,568,000,000 | 22,363,612,000,000 | |||||||||||||||||||||||||||||
financial assets at fair value through other comprehensive income | 34,519,000,000 | ||||||||||||||||||||||||||||||||
liability for defined benefit obligations | 17,935,000,000 | 245,975,000,000 | |||||||||||||||||||||||||||||||
common stock of w5,000 par value | 626,847,000,000 | ||||||||||||||||||||||||||||||||
authorized - 2,000,000,000 shares issued and outstanding -125,369,403 shares in 2018 and 2017 | |||||||||||||||||||||||||||||||||
accumulated other comprehensive income | -29,378,000,000 | 510,124,000,000 | 694,827,000,000 | 237,399,000,000 | 1,309,542,000,000 | 1,005,524,000,000 | 1,182,574,000,000 | 251,161,000,000 | 1,182,573,000,000 | 645,584,000,000 | 242,331,000,000 | 1,781,680,000,000 | 1,153,698,000,000 | ||||||||||||||||||||
trading assets | 30,296,963,000,000 | 26,155,416,000,000 | 26,923,741,000,000 | 8,316,341,000,000 | 3,377,295,000,000 | ||||||||||||||||||||||||||||
financial assets designated at fair value through profit or loss | 3,696,362,000,000 | 3,196,021,000,000 | 3,054,982,000,000 | ||||||||||||||||||||||||||||||
loans | 274,768,543,000,000 | 230,866,992,000,000 | 225,087,048,000,000 | 188,325,465,000,000 | 166,963,829,000,000 | 173,662,000,000,000 | 91,791,255,000,000 | 44,139,000,000,000 | |||||||||||||||||||||||||
held-to-maturity financial assets | 23,800,328,000,000 | 15,606,577,000,000 | 13,608,884,000,000 | 8,012,117,000,000 | |||||||||||||||||||||||||||||
trading liabilities | 2,113,547,000,000 | 3,171,378,000,000 | 2,401,285,000,000 | 428,936,000,000 | 513,061,000,000 | 131,000,000,000 | |||||||||||||||||||||||||||
liabilities held for sale | 164,487,000,000 | ||||||||||||||||||||||||||||||||
total equity attributable to equity holders of shinhan financial group co.,ltd. | 29,282,732,000,000 | ||||||||||||||||||||||||||||||||
investment properties | 738,614,000,000 | ||||||||||||||||||||||||||||||||
non-current assets held for sale | 5,472,000,000 | ||||||||||||||||||||||||||||||||
total equity attributable to equity holder of shinhan bank | 20,473,623,000,000 | ||||||||||||||||||||||||||||||||
equity method accounted investments | 26,506,935,000,000 | 25,035,976,000,000 | |||||||||||||||||||||||||||||||
loans, net of allowance for loan losses | 1,447,725,000,000 | 1,517,375,000,000 | 2,218,850,000,000 | 1,567,125,000,000 | 2,179,050,000,000 | 2,397,950,000,000 | 1,119,375,000,000 | 1,100,292,000,000 | 1,179,147,000,000 | ||||||||||||||||||||||||
debentures,net | 6,226,261,000,000 | 5,588,417,000,000 | 5,593,318,000,000 | ||||||||||||||||||||||||||||||
retirement and severance benefits | 1,205,000,000 | 817,000,000 | 176,766,000,000 | 1,609,000,000 | 1,441,000,000 | 381,000,000,000 | 1,767,000,000 | 961,000,000 | 1,013,000,000 | 1,077,000,000 | 783,000,000 | ||||||||||||||||||||||
stockholders’ equity | 17,952,000,000,000 | ||||||||||||||||||||||||||||||||
capital stock, w5,000 par value authorized 1,000,000,000 shares | |||||||||||||||||||||||||||||||||
issued and outstanding — 474,199,587 shares in 2010 and 2009 | |||||||||||||||||||||||||||||||||
redeemable and convertible preferred stock | 481,475,000,000 | 481,475,000,000 | 481,475,000,000 | 481,475,000,000 | 481,475,000,000 | 481,475,000,000 | 481,475,000,000 | ||||||||||||||||||||||||||
issued and outstanding — 43,711,000 shares in 2010, 53,094,459 shares in 2009 | |||||||||||||||||||||||||||||||||
total stockholders’ equity | 22,261,667,000,000 | 21,489,939,000,000 | 21,123,026,000,000 | 20,728,361,000,000 | 18,782,611,000,000 | 20,728,361,000,000 | 17,605,883,000,000 | 17,725,630,000,000 | 17,605,883,000,000 | 17,977,801,000,000 | 16,691,154,000,000 | 15,431,036,000,000 | 11,361,526,000,000 | 2,154,197,000,000 | 3,395,398,000,000 | 3,262,000,000,000 | |||||||||||||||||
total liabilities and stockholders’ equity | 27,120,706,000,000 | 25,913,566,000,000 | 25,327,528,000,000 | ||||||||||||||||||||||||||||||
equity method investments | 25,505,689,000,000 | ||||||||||||||||||||||||||||||||
capital stock, w5,000 par value | |||||||||||||||||||||||||||||||||
authorized 1,000,000,000 shares | |||||||||||||||||||||||||||||||||
issued and outstanding — 53,094,459 shares in 2010 and 2009 | |||||||||||||||||||||||||||||||||
securities | 51,291,635,000,000 | ||||||||||||||||||||||||||||||||
goodwill | 4,074,710,000,000 | 4,528,000,000,000 | 502,389,000,000 | ||||||||||||||||||||||||||||||
capital stock of w5,000 par value | |||||||||||||||||||||||||||||||||
authorized—1,000,000,000 shares | |||||||||||||||||||||||||||||||||
issued and outstanding: | |||||||||||||||||||||||||||||||||
474,199,587 shares in 2009 | |||||||||||||||||||||||||||||||||
396,199,587 shares in 2008 | |||||||||||||||||||||||||||||||||
issued and outstanding : | |||||||||||||||||||||||||||||||||
53,094,459 shares in 2009 | |||||||||||||||||||||||||||||||||
62,411,251 shares in 2008 | |||||||||||||||||||||||||||||||||
minority interest in consolidated subsidiaries | 397,416,000,000 | -200,000,000 | |||||||||||||||||||||||||||||||
i. cash and due from banks | 429,825,000,000 | 670,815,000,000 | |||||||||||||||||||||||||||||||
1. due from banks | 429,825,000,000 | 670,815,000,000 | |||||||||||||||||||||||||||||||
ii. securities | 25,035,976,000,000 | 22,734,582,000,000 | 23,743,620,000,000 | ||||||||||||||||||||||||||||||
1. equity method investment securities | 25,035,976,000,000 | 22,734,582,000,000 | |||||||||||||||||||||||||||||||
iii. loans | 1,567,125,000,000 | 2,397,950,000,000 | 1,407,925,000,000 | ||||||||||||||||||||||||||||||
allowance for loan losses | -7,875,000,000 | -12,050,000,000 | |||||||||||||||||||||||||||||||
1. loans in won | 1,575,000,000,000 | 2,410,000,000,000 | |||||||||||||||||||||||||||||||
iv. premises and equipment | 1,191,000,000 | 1,473,000,000 | 528,000,000 | ||||||||||||||||||||||||||||||
1. vehicles | 171,000,000 | 171,000,000 | |||||||||||||||||||||||||||||||
accumulated depreciation | -152,000,000 | 137,000,000 | |||||||||||||||||||||||||||||||
2. equipment | 1,673,000,000 | 1,599,000,000 | 1,467,000,000 | ||||||||||||||||||||||||||||||
3. others | 3,169,000,000 | 3,150,000,000 | |||||||||||||||||||||||||||||||
v. other assets | 86,589,000,000 | 108,746,000,000 | 43,461,000,000 | ||||||||||||||||||||||||||||||
allowance for losses | -375,000,000 | -176,000,000 | |||||||||||||||||||||||||||||||
1. guarantee deposits | 8,974,000,000 | 9,982,000,000 | |||||||||||||||||||||||||||||||
2. software | 2,493,000,000 | 764,000,000 | |||||||||||||||||||||||||||||||
3. accounts receivable | 51,358,000,000 | 19,938,000,000 | |||||||||||||||||||||||||||||||
4. accrued income | 8,738,000,000 | 14,160,000,000 | |||||||||||||||||||||||||||||||
5. advance payments | 10,000,000 | 1,242,000,000 | |||||||||||||||||||||||||||||||
6. prepaid expenses | 11,567,000,000 | 59,012,000,000 | |||||||||||||||||||||||||||||||
7. sundry assets | 3,824,000,000 | ||||||||||||||||||||||||||||||||
i. borrowings | 6,267,318,000,000 | 8,233,633,000,000 | 7,293,253,000,000 | ||||||||||||||||||||||||||||||
1. borrowings in won | 674,000,000,000 | 1,155,300,000,000 | |||||||||||||||||||||||||||||||
2. debentures in won | 540,000,000,000 | 7,090,000,000,000 | |||||||||||||||||||||||||||||||
discounts | -8,263,000,000 | -11,667,000,000 | 11,747,000,000 | ||||||||||||||||||||||||||||||
3. debentures in foreign currency | 202,051,000,000 | ||||||||||||||||||||||||||||||||
ii. other liabilities | 125,027,000,000 | 74,050,000,000 | 56,474,000,000 | ||||||||||||||||||||||||||||||
1. taxes withheld | 2,516,000,000 | ||||||||||||||||||||||||||||||||
2. dividends payable | 2,631,000,000 | 2,678,000,000 | |||||||||||||||||||||||||||||||
3. accounts payable | 5,056,000,000 | 1,936,000,000 | |||||||||||||||||||||||||||||||
4. accrued expenses | 98,875,000,000 | 56,113,000,000 | |||||||||||||||||||||||||||||||
5. unearned revenues | 122,000,000 | 8,853,000,000 | |||||||||||||||||||||||||||||||
6. accrued severance benefits | 3,741,000,000 | ||||||||||||||||||||||||||||||||
deposits with insurance company for severance benefits | -2,300,000,000 | -1,531,000,000 | 1,189,000,000 | ||||||||||||||||||||||||||||||
7. derivative liabilities | 14,386,000,000 | ||||||||||||||||||||||||||||||||
i. capital stock | 2,852,473,000,000 | 2,462,473,000,000 | 2,462,473,000,000 | ||||||||||||||||||||||||||||||
1.common stock | 2,370,998,000,000 | 1,980,998,000,000 | 1,980,998,000,000 | ||||||||||||||||||||||||||||||
2. preferred stock | 481,475,000,000 | 481,475,000,000 | |||||||||||||||||||||||||||||||
ii. capital surplus | 9,924,852,000,000 | 9,032,572,000,000 | 8,648,799,000,000 | ||||||||||||||||||||||||||||||
1. paid-in capital in excess of par value | 9,533,986,000,000 | 8,648,726,000,000 | |||||||||||||||||||||||||||||||
2. other capital surplus | 390,866,000,000 | 383,846,000,000 | |||||||||||||||||||||||||||||||
iii. capital adjustment | -417,142,000,000 | -432,887,000,000 | |||||||||||||||||||||||||||||||
1. other | -417,142,000,000 | -432,887,000,000 | |||||||||||||||||||||||||||||||
iv. accumulated other comprehensive income | 1,182,573,000,000 | 242,331,000,000 | 1,644,715,000,000 | ||||||||||||||||||||||||||||||
1. unrealized gain on equity method accounted investments | 1,194,264,000,000 | ||||||||||||||||||||||||||||||||
2. unrealized loss on equity method accounted investments | -7,414,000,000 | ||||||||||||||||||||||||||||||||
3. valuation loss on derivatives | -4,277,000,000 | ||||||||||||||||||||||||||||||||
v. retained earnings | 7,185,605,000,000 | 6,301,394,000,000 | 5,221,814,000,000 | ||||||||||||||||||||||||||||||
1. legal reserve | 1,021,878,000,000 | 819,838,000,000 | |||||||||||||||||||||||||||||||
2. unappropriated retained earnings | 6,163,727,000,000 | 5,481,556,000,000 | |||||||||||||||||||||||||||||||
equity method investment securities | 22,851,101,000,000 | 22,454,612,000,000 | 22,734,582,000,000 | 21,572,214,000,000 | 20,014,778,000,000 | 12,775,892,000,000 | |||||||||||||||||||||||||||
liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||
liabilities: | |||||||||||||||||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||||||||||||||||
authorized — 1,000,000,000 shares | |||||||||||||||||||||||||||||||||
62,411,251 shares in 2009 and 2008 | |||||||||||||||||||||||||||||||||
commitment and contingencies | |||||||||||||||||||||||||||||||||
7. prepaid income taxes | |||||||||||||||||||||||||||||||||
8. sundry assets | 3,824,000,000 | ||||||||||||||||||||||||||||||||
1. withholding taxes | 3,509,000,000 | ||||||||||||||||||||||||||||||||
6. retirement severance benefits | 2,492,000,000 | ||||||||||||||||||||||||||||||||
1. unrealized gain on equity securities under equity method | 267,762,000,000 | ||||||||||||||||||||||||||||||||
2. unrealized loss on equity securities under equity method | -25,431,000,000 | ||||||||||||||||||||||||||||||||
trading securities | 8,838,000,000,000 | ||||||||||||||||||||||||||||||||
investment securities | 38,647,000,000,000 | ||||||||||||||||||||||||||||||||
less allowance for doubtful accounts | -3,317,000,000,000 | ||||||||||||||||||||||||||||||||
issued and outstanding — 396,199,587 shares in 2008 and 2007 | |||||||||||||||||||||||||||||||||
issued and outstanding — 62,411,251 shares in 2008 74,161,377 shares in 2007 | |||||||||||||||||||||||||||||||||
authorized — 1,000,000,000 shares issued and outstanding : | |||||||||||||||||||||||||||||||||
396,199,587 shares in 2008 and 2007 | |||||||||||||||||||||||||||||||||
62,411,251 shares in 2008 74,161,377 shares in 2007 | |||||||||||||||||||||||||||||||||
i. cash & due from banks | 131,994,000,000 | ||||||||||||||||||||||||||||||||
1.due from banks | 131,994,000,000 | ||||||||||||||||||||||||||||||||
1.equity securities accounted for by the equity method | 23,743,620,000,000 | ||||||||||||||||||||||||||||||||
allowance for possible loan losses | |||||||||||||||||||||||||||||||||
1.loans in won | 1,415,000,000,000 | ||||||||||||||||||||||||||||||||
2.loans in foreign currency | |||||||||||||||||||||||||||||||||
3.other | 1,823,000,000 | ||||||||||||||||||||||||||||||||
1.guarantee deposits | 10,068,000,000 | ||||||||||||||||||||||||||||||||
2.software | 1,016,000,000 | ||||||||||||||||||||||||||||||||
3.accounts receivable | |||||||||||||||||||||||||||||||||
4.accrued income | 8,415,000,000 | ||||||||||||||||||||||||||||||||
5.advance payments | 10,000,000 | ||||||||||||||||||||||||||||||||
6.prepaid expenses | 17,060,000,000 | ||||||||||||||||||||||||||||||||
7.prepaid income taxes | 3,651,000,000 | ||||||||||||||||||||||||||||||||
8.sundry assets | 3,241,000,000 | ||||||||||||||||||||||||||||||||
1.borrowings in won | 1,255,000,000,000 | ||||||||||||||||||||||||||||||||
2.borrowings in foreign currency | |||||||||||||||||||||||||||||||||
3.debentures in won | 6,050,000,000,000 | ||||||||||||||||||||||||||||||||
1.taxes withheld | 355,000,000 | ||||||||||||||||||||||||||||||||
2.dividends payable | 2,153,000,000 | ||||||||||||||||||||||||||||||||
3.accounts payable | 702,000,000 | ||||||||||||||||||||||||||||||||
4.accrued expenses | 52,415,000,000 | ||||||||||||||||||||||||||||||||
5.unearned revenues | 135,000,000 | ||||||||||||||||||||||||||||||||
6.accrued severance benefits | 1,903,000,000 | ||||||||||||||||||||||||||||||||
2.preferred stock | 481,475,000,000 | ||||||||||||||||||||||||||||||||
1.paid-in capital in excess of par value | 8,648,726,000,000 | ||||||||||||||||||||||||||||||||
2.other capital surplus | 73,000,000 | ||||||||||||||||||||||||||||||||
1.stock options | |||||||||||||||||||||||||||||||||
1.unrealized gain on equity securities under equity method | 2,314,173,000,000 | ||||||||||||||||||||||||||||||||
2.unrealized loss on equity securities under equity method | |||||||||||||||||||||||||||||||||
1.legal reserve | 580,200,000,000 | ||||||||||||||||||||||||||||||||
2.retained earnings before appropriation | 4,641,614,000,000 | ||||||||||||||||||||||||||||||||
authorized - 1,000,000,000 shares | |||||||||||||||||||||||||||||||||
issued and outstanding - 381,567,614 shares | |||||||||||||||||||||||||||||||||
preferred stock | 481,475,000,000 | 481,475,000,000 | 262,920,000,000 | ||||||||||||||||||||||||||||||
issued and outstanding - 83,478,169 shares in 2007 - 39,767,169 shares in 2006 | |||||||||||||||||||||||||||||||||
issued and outstanding — 381,567,614 shares | |||||||||||||||||||||||||||||||||
issued and outstanding — 83,478,169 shares in 2007 | |||||||||||||||||||||||||||||||||
— 39,767,169 shares in 2006 | |||||||||||||||||||||||||||||||||
fixed assets | 1,686,000,000 | ||||||||||||||||||||||||||||||||
issued and outstanding — 381,567,614 shares in 2006 — 359,207,313 shares in 2005 | |||||||||||||||||||||||||||||||||
issued and outstanding — 39,767,169 shares in 2006 — 74,944,262 shares in 2005 | |||||||||||||||||||||||||||||||||
i. | 468,561,000,000 | ||||||||||||||||||||||||||||||||
1. | 468,561,000,000 | ||||||||||||||||||||||||||||||||
ii. | 12,775,892,000,000 | ||||||||||||||||||||||||||||||||
iii. | 1,179,147,000,000 | ||||||||||||||||||||||||||||||||
2. | 65,072,000,000 | ||||||||||||||||||||||||||||||||
3. | |||||||||||||||||||||||||||||||||
iv. | 1,686,000,000 | ||||||||||||||||||||||||||||||||
v. | 578,345,000,000 | ||||||||||||||||||||||||||||||||
4. | 519,328,000,000 | ||||||||||||||||||||||||||||||||
5. | 1,023,000,000 | ||||||||||||||||||||||||||||||||
6. | 346,000,000 | ||||||||||||||||||||||||||||||||
7. | 1,810,000,000 | ||||||||||||||||||||||||||||||||
i | 2,170,758,000,000 | ||||||||||||||||||||||||||||||||
condensed consolidated balance sheets: | |||||||||||||||||||||||||||||||||
condensed consolidated statements of earnings: | |||||||||||||||||||||||||||||||||
operating revenue | 3,779,757,000,000 | ||||||||||||||||||||||||||||||||
operating expense | 4,446,657,000,000 | ||||||||||||||||||||||||||||||||
operating income | -666,900,000,000 | ||||||||||||||||||||||||||||||||
ordinary income | -691,610,000,000 | ||||||||||||||||||||||||||||||||
net earnings | -718,901,000,000 | ||||||||||||||||||||||||||||||||
goodwill incurred in relation to the acquisition of chohung bank is as follows: | |||||||||||||||||||||||||||||||||
acquisition cost | |||||||||||||||||||||||||||||||||
net asset value | 1,017,739,000,000 | ||||||||||||||||||||||||||||||||
cash and cash equivalents | |||||||||||||||||||||||||||||||||
restricted cash | 3,661,997,000,000 | 1,365,000,000,000 | |||||||||||||||||||||||||||||||
interest-bearing deposits in banks | 409,038,000,000 | ||||||||||||||||||||||||||||||||
call loans and securities purchased under resale agreements | 1,898,219,000,000 | 576,000,000,000 | |||||||||||||||||||||||||||||||
securities: | |||||||||||||||||||||||||||||||||
available-for-sale securities | 18,098,535,000,000 | 8,737,000,000,000 | |||||||||||||||||||||||||||||||
held-to-maturity securities | 3,604,810,000,000 | 4,408,000,000,000 | |||||||||||||||||||||||||||||||
customers’ liability on acceptances | 2,364,656,000,000 | 928,000,000,000 | |||||||||||||||||||||||||||||||
premises and equipment | 2,002,724,000,000 | 828,000,000,000 | |||||||||||||||||||||||||||||||
security deposits | 966,341,000,000 | 466,000,000,000 | |||||||||||||||||||||||||||||||
deposits: | |||||||||||||||||||||||||||||||||
interest-bearing | |||||||||||||||||||||||||||||||||
noninterest-bearing | 1,328,203,000,000 | ||||||||||||||||||||||||||||||||
acceptances outstanding | 2,364,656,000,000 | 928,000,000,000 | |||||||||||||||||||||||||||||||
short-term borrowings | 11,204,739,000,000 | 6,994,000,000,000 | |||||||||||||||||||||||||||||||
secured borrowings | 6,316,260,000,000 | 4,706,000,000,000 | |||||||||||||||||||||||||||||||
long-term debt | 21,217,708,000,000 | 8,235,000,000,000 | |||||||||||||||||||||||||||||||
accrued expenses and other liabilities | 6,554,588,000,000 | 3,193,000,000,000 | |||||||||||||||||||||||||||||||
commitments and contingencies | |||||||||||||||||||||||||||||||||
minority interest | 582,645,000,000 | 288,000,000,000 | |||||||||||||||||||||||||||||||
redeemable convertible preferred stock | 711,134,000,000 | ||||||||||||||||||||||||||||||||
additional paid-in capital | 1,073,307,000,000 | 1,048,000,000,000 | |||||||||||||||||||||||||||||||
accumulated other comprehensive income, net of taxes | 58,096,000,000 | 70,000,000,000 | |||||||||||||||||||||||||||||||
less: treasury stock, at cost, 29,874,062 shares in 2002 and 29,873,359 shares in 2003 | -396,700,000,000 | ||||||||||||||||||||||||||||||||
total liabilities, minority interest, redeemable convertible preferred stock and stockholders’ equity | |||||||||||||||||||||||||||||||||
interest-bearing deposits | 125,000,000,000 | ||||||||||||||||||||||||||||||||
trading assets: | |||||||||||||||||||||||||||||||||
trading securities and other | 926,000,000,000 | ||||||||||||||||||||||||||||||||
derivatives assets | 139,000,000,000 | ||||||||||||||||||||||||||||||||
goodwill and intangible assets | 219,000,000,000 | ||||||||||||||||||||||||||||||||
non-interest-bearing | 1,163,000,000,000 | ||||||||||||||||||||||||||||||||
future policy benefit | |||||||||||||||||||||||||||||||||
less: treasury stock, at cost | -395,000,000,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-05-15 | 2019-05-21 | 2019-03-11 | 2017-11-14 | 2015-08-17 | 2015-05-15 | 2015-03-10 | 2011-11-29 | 2010-03-31 | 2009-05-15 | 2008-08-14 | 2006-11-21 | 2004-04-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||
profit for the period | 2,499,281,000,000 | ||||||||||||
adjustments for: | |||||||||||||
interest income | -21,581,000,000 | -11,962,000,000 | -1,987,231,000,000 | -19,931,000,000 | -29,141,000,000 | -14,796,000,000 | -461,000,000 | ||||||
interest expense | 83,318,000,000 | 50,188,000,000 | 421,943,000,000 | 134,259,000,000 | 125,754,000,000 | 63,178,000,000 | 4,492,000,000 | 2,492,000,000 | |||||
dividend income | -2,560,051,000,000 | -1,282,144,000,000 | -1,393,000,000 | -930,112,000,000 | -1,063,347,000,000 | -1,063,347,000,000 | -93,478,000,000 | ||||||
income tax expense | 6,376,000,000 | ||||||||||||
net gain on financial instruments at fair value through profit or loss | -9,872,000,000 | ||||||||||||
benefit from (reversal of) credit loss allowance | |||||||||||||
employee benefits | |||||||||||||
depreciation and amortization | 1,043,000,000 | 643,000,000 | 372,000,000 | 323,000,000 | 165,000,000 | 202,950,000,000 | 922,000,000 | ||||||
net foreign currency translation gain | -28,000,000 | -1,242,000,000 | |||||||||||
other non-operating expense | |||||||||||||
changes in assets and liabilities: | |||||||||||||
financial instruments at fair value through profit or loss | -2,034,449,000,000 | ||||||||||||
other assets | -751,000,000 | -737,000,000 | -185,649,000,000 | 435,000,000 | -1,843,000,000 | 8,000,000 | -1,102,280,000,000 | -5,238,000,000 | |||||
net defined benefit assets | |||||||||||||
other liabilities | -7,557,000,000 | -5,023,000,000 | 93,155,000,000 | -6,048,000,000 | -8,295,000,000 | -4,769,000,000 | 1,690,470,000,000 | -2,803,000,000 | |||||
interest received | 32,335,000,000 | 13,645,000,000 | 1,832,758,000,000 | 18,882,000,000 | 29,172,000,000 | 14,954,000,000 | 8,583,274,000,000 | ||||||
interest paid | -102,764,000,000 | -49,192,000,000 | -420,582,000,000 | -131,450,000,000 | -125,084,000,000 | -62,119,000,000 | -4,151,427,000,000 | ||||||
dividends received | 930,112,000,000 | 129,712,000,000 | 5,618,000,000 | 186,896,000,000 | |||||||||
income tax paid | -1,820,000,000 | -1,017,000,000 | -384,490,000,000 | ||||||||||
net cash inflow from operating activities | |||||||||||||
cash flows from investing activities | |||||||||||||
acquisition of financial assets at fair value through profit or loss | |||||||||||||
decrease in financial assets at fair value through profit or loss | |||||||||||||
lending of loans at amortized cost | -269,693,000,000 | -98,000,000,000 | |||||||||||
collection of loans at amortized cost | 790,300,000,000 | 467,669,000,000 | |||||||||||
acquisition of property and equipment | -53,000,000 | -212,000,000 | -21,404,000,000 | -1,140,000,000 | -126,000,000 | -80,000,000 | -234,000,000 | ||||||
disposal of property and equipment | |||||||||||||
acquisition of intangible assets | -377,000,000 | -20,670,000,000 | -47,000,000 | -31,000,000 | -326,000,000 | ||||||||
disposal of intangible assets | 132,000,000 | 75,000,000 | |||||||||||
increase in other assets | -8,225,000,000 | -33,307,000,000 | -2,053,000,000 | -2,162,000,000 | 25,660,000,000 | -1,637,000,000 | -51,676,000,000 | -21,526,000,000 | |||||
decrease in other assets | 959,000,000 | 3,710,000,000 | 60,579,000,000 | 606,000,000 | 13,675,000,000 | ||||||||
acquisition of investments in subsidiaries | -100,054,000,000 | -2,082,498,000,000 | |||||||||||
disposal of investments in subsidiaries | |||||||||||||
net cash inflow from investing activities | |||||||||||||
cash flows from financing activities | |||||||||||||
issuance of hybrid bonds | 398,835,000,000 | 224,466,000,000 | 199,455,000,000 | ||||||||||
redemption of hybrid bonds | -300,000,000,000 | -1,000,000,000,000 | |||||||||||
issuance of debt securities | 599,030,000,000 | 724,000,000,000 | 1,500,000,000,000 | 300,000,000,000 | |||||||||
redemption of debt securities issued | |||||||||||||
increase in borrowings | 9,700,000,000 | 90,000,000,000 | 290,000,000,000 | 130,009,000,000 | |||||||||
decrease in borrowings | -20,000,000,000 | 70,000,000,000 | |||||||||||
dividends paid | -48,668,000,000 | -50,947,000,000 | -600,018,000,000 | -702,036,000,000 | -526,643,000,000 | -33,806,000,000 | -459,901,000,000 | -585,520,000,000 | -245,034,000,000 | -245,022,000,000 | 110,000,000 | -157,017,000,000 | |
acquisition of treasury stock | -276,260,000,000 | -11,756,000,000 | |||||||||||
disposal of treasury stock | |||||||||||||
costs for retirement of treasury stock | |||||||||||||
repayments of leased liabilities | -171,000,000 | -304,000,000 | |||||||||||
net cash outflow from financing activities | |||||||||||||
net increase in cash and cash equivalents | 50,010,000,000 | 5,000,000 | -120,809,000,000 | -455,157,000,000 | -462,823,000,000 | -5,260,000,000 | |||||||
cash and cash equivalents at the beginning of the period | 151,204,000,000 | ||||||||||||
cash and cash equivalents at the end of the period | 376,767,000,000 | ||||||||||||
corporate tax expense | 1,592,000,000 | ||||||||||||
employee costs | 690,000,000 | 2,282,000,000 | 3,467,000,000 | 1,924,000,000 | 950,000,000 | ||||||||
non-operating expense | 2,270,000,000 | 7,000,000 | 2,000,000 | 1,000,000 | |||||||||
effect on the exchange rate changes of cash equivalents in foreign currency | |||||||||||||
net increase(decrease) in cash and cash equivalents | 225,563,000,000 | ||||||||||||
benefit from(reversal of) credit loss allowance | -73,000,000 | ||||||||||||
net defined benefit asset | -235,000,000 | ||||||||||||
dividend received | 2,554,854,000,000 | 1,268,720,000,000 | 1,393,000,000 | 1,063,347,000,000 | 1,061,823,000,000 | ||||||||
net cash from operating activities | 436,202,000,000 | 1,260,029,000,000 | -2,385,236,000,000 | 570,592,000,000 | 307,012,000,000 | -336,358,000,000 | -1,785,704,000,000 | -634,622,000,000 | 7,796,000,000 | 55,066,000,000 | 1,272,655,000,000 | -59,573,000,000 | -12,347,000,000 |
capital expenditures | -53,000,000 | -212,000,000 | -21,404,000,000 | -1,140,000,000 | -126,000,000 | -80,000,000 | -128,279,000,000 | -234,000,000 | -199,000,000 | -16,000,000 | -1,355,000,000 | 0 | 0 |
free cash flows | 436,149,000,000 | 1,259,817,000,000 | -2,406,640,000,000 | 569,452,000,000 | 306,886,000,000 | -336,438,000,000 | -1,913,983,000,000 | -634,856,000,000 | 7,597,000,000 | 55,050,000,000 | 1,271,300,000,000 | -59,573,000,000 | -12,347,000,000 |
net cash from investing activities | 411,898,000,000 | -1,712,082,000,000 | -43,854,000,000 | -380,605,000,000 | -98,000,000 | -111,000,000 | 1,299,514,000,000 | 197,387,000,000 | 855,323,000,000 | 258,385,000,000 | -94,460,000,000 | -2,118,074,000,000 | |
repayments of debt securities issued | -1,285,000,000,000 | -324,000,000,000 | -910,000,000,000 | -400,000,000,000 | -50,000,000,000 | ||||||||
retirement costs of treasury stock | |||||||||||||
net cash inflow from financing activities | -622,537,000,000 | ||||||||||||
net defined benefit liabilities | |||||||||||||
conversion costs for preferred stock | |||||||||||||
net decrease in cash and cash equivalents | -15,561,000,000 | -120,810,000,000 | |||||||||||
profit for the year | |||||||||||||
adjustment for: | |||||||||||||
fee and commission income | |||||||||||||
fee and commission expense | 745,000,000 | ||||||||||||
net gain on sales of financial assets at fair value through profit or loss | -6,413,000,000 | ||||||||||||
net income on sales of financial assets at fair value through profit or loss | |||||||||||||
net gain on valuation of financial assets at fair value through profit or loss | |||||||||||||
net income on valuation of financial assets at fair value through profit or loss | |||||||||||||
net gain on valuation and transaction of derivatives | |||||||||||||
net income on valuation and transaction of derivatives | |||||||||||||
net gain on foreign currency transaction | |||||||||||||
net income on foreign currency transaction | |||||||||||||
benefit from credit loss allowance | |||||||||||||
employee expenses | |||||||||||||
depreciation expenses | |||||||||||||
increase in restoration liabilities | |||||||||||||
other operating income | -2,332,000,000 | ||||||||||||
other operating expenses | 51,249,000,000 | ||||||||||||
non-operating income | |||||||||||||
non-operating expenses | 795,000,000 | ||||||||||||
equity method loss | |||||||||||||
restricted due from banks | |||||||||||||
due from banks at amortized cost | |||||||||||||
financial assets at fair value through profit or loss | 30,159,000,000 | -146,748,000,000 | |||||||||||
credit card receivables at amortized cost and other | |||||||||||||
lease assets | -313,210,000,000 | ||||||||||||
net defined benefit obligations | |||||||||||||
provisions | -3,126,000,000 | -68,123,000,000 | |||||||||||
income taxes paid | -159,625,000,000 | ||||||||||||
net cash inflow(outflow) from operating activities | |||||||||||||
proceeds from disposal of financial assets at fair value through profit or loss | |||||||||||||
profit before income taxes | 1,248,439,000,000 | ||||||||||||
net fees and commission expense | |||||||||||||
net insurance contract income | |||||||||||||
net insurance finance expense | |||||||||||||
net income on derivatives | |||||||||||||
net gain on foreign currency translation | |||||||||||||
net gain on financial instruments designated at fair value through profit or loss | |||||||||||||
net income on disposal of securities at fair value through other comprehensive income | |||||||||||||
benefit from allowance for credit loss | |||||||||||||
net gain on disposal of securities at amortized cost | |||||||||||||
depreciation and other amortization | |||||||||||||
other operating expense | |||||||||||||
equity method income | |||||||||||||
securities at fair value through profit or loss | |||||||||||||
loans at fair value through profit or loss | |||||||||||||
financial instruments designated at fair value through profit or loss | |||||||||||||
derivative instruments | |||||||||||||
loans at amortized cost | |||||||||||||
insurance contract assets | |||||||||||||
reinsurance contract assets | |||||||||||||
deposits | 14,691,990,000,000 | ||||||||||||
insurance contract liabilities | |||||||||||||
reinsurance contract liabilities | |||||||||||||
investment contract liabilities | |||||||||||||
decrease in financial instruments at fair value through profit or loss | |||||||||||||
acquisition of financial instruments at fair value through profit or loss | |||||||||||||
decrease in financial securities at fair value through other comprehensive income | |||||||||||||
acquisition of securities at fair value through other comprehensive income | |||||||||||||
decrease in securities at amortized cost | |||||||||||||
acquisition of securities at amortized cost | |||||||||||||
proceeds from disposal of property and equipment | 345,000,000 | ||||||||||||
proceeds from disposal of intangible assets | 93,000,000 | ||||||||||||
proceeds from disposal of investments in associates | |||||||||||||
acquisition of investments in associates | -3,940,000,000 | ||||||||||||
proceeds from disposal of investment property | |||||||||||||
acquisition of investment property | |||||||||||||
disposal of assets held-for-sale | |||||||||||||
change in other assets | |||||||||||||
proceeds from settlement of hedging derivative financial instruments | |||||||||||||
payment of settlement of hedging derivative financial instruments | |||||||||||||
net cash flows from business combinations | |||||||||||||
net cash outflow from investing activities | |||||||||||||
net change in borrowings | |||||||||||||
proceeds from debt securities issued | 300,000,000,000 | ||||||||||||
increase in financial liabilities designated at fair value through profit or loss | |||||||||||||
changes in other liabilities | |||||||||||||
proceeds and costs from retirement of treasury stock | |||||||||||||
increase(decrease) in non-controlling interests | |||||||||||||
redemption of lease liabilities | |||||||||||||
conversion costs for preferred stock to common stock | |||||||||||||
effect of exchange rate changes on cash and cash equivalents held | |||||||||||||
increase in cash and cash equivalents | 1,022,729,000,000 | ||||||||||||
net profit or loss on financial instruments at fair value through profit or loss | |||||||||||||
reversal of credit loss allowance | |||||||||||||
due from banks | -3,938,012,000,000 | ||||||||||||
acquisition of investment in subsidiary | |||||||||||||
repayments of hybrid bonds | |||||||||||||
repayments of debt securities | -5,989,635,000,000 | ||||||||||||
convertible preferred stock conversion cost | |||||||||||||
payment for disposal of treasury stock | |||||||||||||
repayments of lease liabilities | |||||||||||||
cash and cash equivalents at the beginning of year | 291,126,000,000 | ||||||||||||
cash and cash equivalents at the end of year | 341,136,000,000 | ||||||||||||
net gain on financial assets at fair value through profit or loss | -274,000,000 | ||||||||||||
provision for (reversal of) credit loss allowance | -190,000,000 | ||||||||||||
adjustments for: - sum | -1,245,031,000,000 | -821,424,000,000 | -812,227,000,000 | -967,375,000,000 | -1,014,608,000,000 | ||||||||
liability for defined benefit obligations | 56,000,000 | -15,171,000,000 | -784,000,000 | -784,000,000 | -97,292,000,000 | 10,000,000 | |||||||
changes in assets and liabilities: - sum | 24,455,000,000 | -3,516,396,000,000 | -237,220,000,000 | -668,143,000,000 | -1,354,731,000,000 | ||||||||
debenture issuance costs paid | -501,000,000 | -2,412,000,000 | |||||||||||
proceeds from borrowings | 100,000,000,000 | 2,608,414,000,000 | 90,000,000,000 | 21,940,317,000,000 | |||||||||
net cash from financing activities | 436,492,000,000 | 2,479,100,000,000 | -189,982,000,000 | -427,723,000,000 | 215,659,000,000 | 28,926,000,000 | 1,459,964,000,000 | -1,104,109,000,000 | 460,238,000,000 | -308,790,000,000 | 2,125,161,000,000 | ||
cash and cash equivalents at beginning of period | 48,628,000,000 | 39,000,000 | 120,810,000,000 | 120,810,000,000 | 609,865,000,000 | 749,368,000,000 | |||||||
cash and cash equivalents at end of period | 33,067,000,000 | ||||||||||||
profit before income tax | 698,640,000,000 | ||||||||||||
fee and commission income before k-ifrs no.1115 | |||||||||||||
consideration paid to customers | 176,178,000,000 | ||||||||||||
net gain on valuation of trading financial assets | |||||||||||||
net loss on valuation of financial assets at fair value through profit or loss | 223,000,000 | ||||||||||||
net loss on valuation and transaction of derivatives | -4,670,000,000 | ||||||||||||
net loss on foreign currency transaction | 4,670,000,000 | ||||||||||||
net gain on sales of available-for-sale financial assets | -427,992,000,000 | ||||||||||||
bad debt expenses | |||||||||||||
reversal of allowance for unused loan commitments | |||||||||||||
provision for credit loss allowance | 469,362,000,000 | ||||||||||||
net impairment loss on financial assets | 463,724,000,000 | ||||||||||||
general administrative expenses | 48,525,000,000 | ||||||||||||
impairment loss on investments in associates | 4,593,000,000 | ||||||||||||
trading financial assets | |||||||||||||
loans and receivables | |||||||||||||
credit card assets at amortized cost, etc. | -2,945,647,000,000 | ||||||||||||
note | 2,018,000,000 | ||||||||||||
decrease in restricted due from banks | 340,000,000 | ||||||||||||
proceeds from disposal of financial assets at fair value through profit and loss | 6,413,000,000 | ||||||||||||
acquisition of financial assets at fair value through profit and loss | -710,000,000 | ||||||||||||
proceeds from disposal of available-for-sale financial assets | |||||||||||||
acquisition of available-for-sale financial assets | |||||||||||||
proceeds from disposal of financial assets at fair value through other comprehensive income | 200,000,000 | ||||||||||||
acquisition of financial assets at fair value through other comprehensive income | -300,000,000 | ||||||||||||
decrease in guarantee deposits | 48,941,000,000 | ||||||||||||
increase in guarantee deposits | -53,162,000,000 | ||||||||||||
repayment of borrowings | -1,817,949,000,000 | -1,155,300,000,000 | -100,000,000,000 | ||||||||||
proceeds from debentures | 4,955,308,000,000 | ||||||||||||
repayment of debentures | -2,666,655,000,000 | -1,425,126,000,000 | -2,190,000,000,000 | -520,000,000,000 | |||||||||
cash outflows from cash flow hedges | |||||||||||||
net trading income | -474,000,000 | -2,830,000,000 | -751,000,000 | -9,885,000,000 | |||||||||
provision for (reversal of) credit losses | 185,000,000 | -60,000,000 | -8,000,000 | ||||||||||
trading assets | -230,947,000,000 | -657,221,000,000 | -1,349,186,000,000 | -789,460,000,000 | -1,688,011,000,000 | ||||||||
liabilities for defined benefit obligations | -660,000,000 | ||||||||||||
tax refund | 100,000,000 | ||||||||||||
lending loans | -550,000,000,000 | ||||||||||||
collection of loans | 200,000,000,000 | 855,000,000,000 | 890,000,000,000 | 230,000,000,000 | 165,000,000,000 | ||||||||
redemption of preferred stocks | |||||||||||||
issuance of loans | |||||||||||||
repayments of borrowings | -90,000,000,000 | -90,000,000,000 | -19,232,423,000,000 | ||||||||||
debentures issuance cost paid | -535,000,000 | -535,000,000 | -8,520,000,000 | -2,401,000,000 | 787,000,000 | ||||||||
lending of loans | |||||||||||||
net interest income | -4,367,133,000,000 | ||||||||||||
gain on financial instruments designated at fair value through profit or loss | -34,000,000 | ||||||||||||
non-cash trading loss | 151,398,000,000 | ||||||||||||
non-cash foreign currencies transaction gain | -81,300,000,000 | ||||||||||||
net impairment loss on other financial assets | 220,286,000,000 | ||||||||||||
non-cash employee benefits | 109,749,000,000 | ||||||||||||
non-cash other operating expenses (income) | -31,542,000,000 | ||||||||||||
share of profit of associates | -11,808,000,000 | ||||||||||||
non-cash non-operating expenses | 10,429,000,000 | ||||||||||||
derivative assets | 1,307,983,000,000 | ||||||||||||
loans | -14,294,992,000,000 | ||||||||||||
financial liabilities designated at fair value through profit or loss | 6,171,000,000 | ||||||||||||
trading liabilities | 13,303,000,000 | ||||||||||||
derivative liabilities | -1,363,576,000,000 | ||||||||||||
proceeds from sale of available-for-sale financial assets | |||||||||||||
proceeds from redemption of held-to-maturity financial assets | 2,478,775,000,000 | ||||||||||||
proceeds from sale of property and equipment | 17,843,000,000 | ||||||||||||
proceeds from sale of intangible assets | 3,253,000,000 | ||||||||||||
proceeds from sale of investments in associates | |||||||||||||
proceeds from sale of non-current assets held for sale | 3,243,000,000 | ||||||||||||
proceeds from sale of investment properties | |||||||||||||
acquisitions of available-for-sale financial assets | -19,883,814,000,000 | ||||||||||||
acquisitions of held-to-maturity financial assets | -3,046,469,000,000 | ||||||||||||
acquisitions of property and equipment | -128,279,000,000 | ||||||||||||
acquisitions of intangible assets | -18,078,000,000 | ||||||||||||
acquisitions of investments in associates | |||||||||||||
payment of guarantee deposits | -372,978,000,000 | ||||||||||||
receipts of refund of guarantee deposits paid | 433,103,000,000 | ||||||||||||
proceeds from issuance of debt securities | 4,789,496,000,000 | ||||||||||||
proceeds from hybrid bonds | |||||||||||||
receipts of guarantee deposits for lease | 10,045,000,000 | ||||||||||||
refund of guarantee deposits for lease | -28,973,000,000 | ||||||||||||
effect of exchange rate fluctuations on cash and cash equivalents held | 2,107,000,000 | ||||||||||||
cash and cash equivalents at january 1 | 4,991,361,000,000 | ||||||||||||
cash and cash equivalents at december 31 | |||||||||||||
net income for the period | |||||||||||||
net foreign currency transaction loss | 21,594,000,000 | ||||||||||||
provision for credit losses | 81,000,000 | ||||||||||||
noncash employee benefit | -7,091,000,000 | ||||||||||||
noncash other operating income | -21,594,000,000 | ||||||||||||
issuance of loan | -655,000,000,000 | ||||||||||||
investments in subsidiaries | |||||||||||||
cash flow from financing activities | |||||||||||||
issuance of preferred stock | 1,110,000,000,000 | ||||||||||||
issuance of debentures | 2,340,000,000,000 | ||||||||||||
stock issuance cost paid | -3,836,000,000 | -35,141,000,000 | -35,140,000,000 | 29,000,000 | |||||||||
inflow from hedging activities | 32,966,000,000 | ||||||||||||
net income | |||||||||||||
adjustments for : | |||||||||||||
depreciation | 460,000,000 | 115,000,000 | 236,000,000 | 159,000,000 | 568,000,000 | ||||||||
amortization | 433,000,000 | 102,000,000 | 148,000,000 | 74,000,000 | 109,000,000 | ||||||||
provision for (reversal of) allowance for loan losses and other assets | -3,975,000,000 | ||||||||||||
provision for retirement and severance benefits | 1,425,000,000 | 542,000,000 | 252,000,000 | ||||||||||
gain from equity method accounted investments ,net | -1,510,820,000,000 | ||||||||||||
gain from disposition of equity method accounted investments | -10,509,000,000 | ||||||||||||
gain from disposition of property and equipment | -38,000,000 | ||||||||||||
share-based compensation costs | 9,433,000,000 | -3,829,000,000 | |||||||||||
other | 5,334,000,000 | 2,431,000,000 | 643,000,000 | ||||||||||
changes in assets and liabilities : | |||||||||||||
dividends received from equity method accounted investments | 161,451,000,000 | ||||||||||||
increase in other liabilities | -11,324,000,000 | -2,561,000,000 | 10,452,000,000 | 1,893,000,000 | 23,510,000,000 | ||||||||
retirement and severance benefits paid | -1,051,000,000 | -371,000,000 | -238,000,000 | ||||||||||
succession in accrued severance benefits | 875,000,000 | ||||||||||||
decrease in deposit for severance benefit insurance | -769,000,000 | 182,000,000 | 259,000,000 | 10,000,000 | |||||||||
cash flows from investing activities: | |||||||||||||
cash from investing activities: | |||||||||||||
decrease in equity method accounted investments | 52,665,000,000 | ||||||||||||
disposition of property and equipment | 59,000,000 | ||||||||||||
cash from investing activities: - sum | 943,732,000,000 | 253,491,000,000 | 1,066,377,000,000 | 55,640,000,000 | 188,456,000,000 | ||||||||
purchase of equity method accounted investments | -31,048,000,000 | ||||||||||||
loan originations | -55,000,000,000 | -50,000,000,000 | |||||||||||
purchase of property and equipment | -199,000,000 | -16,000,000 | -1,355,000,000 | ||||||||||
cash from financing activities: | |||||||||||||
proceeds from issuance of debentures | 500,000,000,000 | ||||||||||||
proceeds from issuance of debentures in foreign currency | 212,160,000,000 | ||||||||||||
proceeds from issuance of common stock | 1,310,400,000,000 | 1,310,400,000,000 | |||||||||||
repayment of preferred stocks | -172,793,000,000 | ||||||||||||
net increase in cash and due from banks | -240,990,000,000 | 690,492,000,000 | |||||||||||
cash and due from banks at beginning of year | 670,815,000,000 | 670,815,000,000 | |||||||||||
cash and due from banks at end of year | |||||||||||||
cash flows from operating activities: | |||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||
provision for (reversal of) allowance for loan losses | -996,000,000 | 3,200,000,000 | 495,000,000 | ||||||||||
gain from equity method investment securities | -169,923,000,000 | ||||||||||||
interest expenses | 1,426,000,000 | ||||||||||||
dividends received from equity method investment securities | 86,241,000,000 | 1,331,848,000,000 | |||||||||||
decrease in equity method investment securities | 22,885,000,000 | 900,283,000,000 | |||||||||||
purchase of equity method investment securities | -27,745,000,000 | ||||||||||||
cash flows from financing activities: | |||||||||||||
benefit from (reversal of) allowance for loan losses and other assets | |||||||||||||
benefit from retirement and severance benefits | |||||||||||||
decrease (increase) in other assets | |||||||||||||
provision for future policy benefit | |||||||||||||
accretion of discounts on long-term debt | |||||||||||||
amortization on deferred loan origination fees and costs | |||||||||||||
amortization on investment debt securities | |||||||||||||
net gain on equity investments | |||||||||||||
net trading (profits) losses | |||||||||||||
net gain on sale of available-for-sale securities | |||||||||||||
impairment loss on securities | |||||||||||||
net loss on sale of premises and equipment | |||||||||||||
provision (reversal) for other losses | |||||||||||||
net gain on sales of other assets | |||||||||||||
net unrealized foreign exchange loss | |||||||||||||
minority interest in net income of subsidiaries | |||||||||||||
expense (reversal) on stock option | |||||||||||||
impairment loss on goodwill | |||||||||||||
impairment loss on other investments | |||||||||||||
cumulative effect of change in accounting principle | |||||||||||||
net loss on sale of loans | |||||||||||||
net changes in: | |||||||||||||
restricted cash | |||||||||||||
accrued expenses and other liabilities | |||||||||||||
net change in interest-bearing deposit assets | |||||||||||||
net change in call loans and securities purchased under resale agreements | |||||||||||||
proceeds from sales of available-for-sale securities | |||||||||||||
proceeds from maturities of available-for-sale securities | |||||||||||||
purchases of available-for-sale securities | |||||||||||||
proceeds from maturities of held-to-maturity securities | |||||||||||||
purchases of held-to-maturity securities | |||||||||||||
loan originations and principal collections | |||||||||||||
proceeds from sales of premises and equipment | |||||||||||||
purchases of premises and equipment | |||||||||||||
net change in security deposits | |||||||||||||
acquisition of subsidiaries, net of cash acquired | |||||||||||||
proceeds from sales of equity method investments | |||||||||||||
acquisition of equity method investments | |||||||||||||
net change in other investments | |||||||||||||
net increase in interest-bearing deposit liabilities | |||||||||||||
net increase in non-interest-bearing deposits | |||||||||||||
net increase in short-term borrowings | |||||||||||||
proceeds from issuance of secured borrowings | |||||||||||||
repayment of secured borrowings | |||||||||||||
proceeds from issuance of long-term debt | |||||||||||||
repayment of long-term debt | |||||||||||||
issuance of redeemable convertible preferred stock | |||||||||||||
issuance of redeemable preferred stock | |||||||||||||
purchases of treasury stock | |||||||||||||
sale of treasury stock | |||||||||||||
cash dividends paid | |||||||||||||
increase of minority interest | |||||||||||||
effect of exchange rate changes on cash | |||||||||||||
cash and cash equivalents | |||||||||||||
beginning of year | |||||||||||||
end of year | |||||||||||||
supplemental disclosure of cash flow information | |||||||||||||
cash paid for interest | |||||||||||||
cash paid for income taxes | |||||||||||||
supplemental disclosure of non-cash investing and financing activities | |||||||||||||
acquisitions: | |||||||||||||
fair value of net assets acquired | |||||||||||||
goodwill | |||||||||||||
consideration other than cash | |||||||||||||
conversion of redeemable convertible preferred stock into common stock: | |||||||||||||
common stock | |||||||||||||
additional paid-in-capital | |||||||||||||
securities and other investments received in connection with loan restructuring | |||||||||||||
increase in cumulative translation adjustments, net of taxes | |||||||||||||
increase in unrealized gains on available-for-sale securities, net of taxes | |||||||||||||
increase in premises and equipment transferred from other receivables | |||||||||||||
benefit from allowance for loan losses | |||||||||||||
equity from earnings of equity method investment securities | -1,497,702,000,000 | ||||||||||||
stock compensation costs | -3,538,000,000 | 1,127,000,000 | 1,381,000,000 | ||||||||||
decrease in property and equipment | |||||||||||||
loans granted | -805,000,000,000 | ||||||||||||
proceeds from issuance of preferred stock | |||||||||||||
redemption of redeemable preferred stocks | |||||||||||||
cash and due from banks at beginning of period | |||||||||||||
cash and due from banks at end of period | |||||||||||||
reversal of allowance for loan losses | |||||||||||||
increase in deposit for severance benefit insurance | -198,000,000 | ||||||||||||
decrease in advance payments | |||||||||||||
decrease in other liabilities | |||||||||||||
provision for retirement and severance benefit | 501,000,000 | 140,000,000 | |||||||||||
gain from equity method | -522,943,000,000 | ||||||||||||
retirement and severance benefit paid | -22,000,000 | -180,000,000 | |||||||||||
decrease in loans | 50,000,000,000 | ||||||||||||
decrease in fixed assets | 22,000,000 | ||||||||||||
increase in equity method investment securities | |||||||||||||
increase in loans | 150,000,000,000 | -1,176,009,000,000 | |||||||||||
increase in fixed assets | 100,000,000 | ||||||||||||
increase in debentures | 200,000,000,000 | 1,250,000,000,000 | |||||||||||
proceeds from disposition of treasury stock | |||||||||||||
cash from financing activities: - sum | 490,000,000,000 | 2,307,657,000,000 | |||||||||||
decrease in debentures | 30,000,000,000 | ||||||||||||
decrease in redeemable preferred stocks | 697,864,000,000 | ||||||||||||
depreciation expense | |||||||||||||
amortization expense | |||||||||||||
provision for loan losses | |||||||||||||
foreign currency related gain | |||||||||||||
purchase of fixed assets | |||||||||||||
proceeds from reissuance of treasury stock | |||||||||||||
debenture issue costs | |||||||||||||
reacquisition of treasury stock | |||||||||||||
net earnings | |||||||||||||
adjustments to reconcile net earnings to net cash from operating activities: | |||||||||||||
bad debts | 5,879,000,000 | ||||||||||||
loss from sale of investment securities accounted for by the equity method | 166,000,000 | ||||||||||||
loss from sale of available-for-sale securities | 1,725,000,000 | ||||||||||||
valuation gain using the equity method | -388,641,000,000 | ||||||||||||
proceeds from sale of investment securities accounted for by the equity method | 1,529,000,000 | ||||||||||||
proceeds from sale of available-for-sale securities | 2,000,000 | ||||||||||||
proceeds from disposition of fixed assets | 29,000,000 | ||||||||||||
purchases of investment securities accounted for by the equity method | -1,128,423,000,000 | ||||||||||||
purchases of fixed assets | -993,000,000 | ||||||||||||
issuance of additional shares | 927,648,000,000 | ||||||||||||
redemption of borrowings | |||||||||||||
issuance cost on debentures paid | -3,871,000,000 | ||||||||||||
issuance cost on additional shares paid | -21,608,000,000 | ||||||||||||
cash and cash equivalents at beginning of year | 10,613,000,000 | ||||||||||||
cash and cash equivalents at end of year | |||||||||||||
less: net income of subsidiaries | |||||||||||||
parent company net income | |||||||||||||
depreciation on premises and equipment | |||||||||||||
grant of stock options | |||||||||||||
cash dividends from subsidiaries | |||||||||||||
loss on disposition of investment (at equity) in subsidiaries | |||||||||||||
loss on disposition of available-for-sales securities | |||||||||||||
interest expense on debentures | |||||||||||||
other interest expense | |||||||||||||
net change in deposits with banking subsidiaries | |||||||||||||
advances to, and receivables from, subsidiaries | |||||||||||||
purchases of investment (at equity) in subsidiaries | |||||||||||||
disposition of investment (at equity) in subsidiaries | |||||||||||||
available-for-sales securities: | |||||||||||||
proceeds from issuance of long term debt | |||||||||||||
repayments of long term debt | |||||||||||||
proceeds from issuance of common stock and stock related awards | |||||||||||||
net increase in cash on hand | |||||||||||||
cash on hand at the beginning of the period | |||||||||||||
cash on hand at the end of the period | |||||||||||||
cash on hand paid for interest |
